LOKIASV2_0141_ESMFold_hypothetical_protein	4ww9-assembly1.cif.gz_A	4ww9-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121 in complex with ADP	5.094E-07	1.000	205	35	261	284	15	238	238	250	0.799	0.941
LOKIASV2_0141_ESMFold_hypothetical_protein	4ww7-assembly1.cif.gz_A	4ww7-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121 in complex with AMP	1.803E-06	1.000	191	35	251	284	15	234	237	240	0.764	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_A	2pup-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	3.575E-06	1.000	188	9	284	284	6	356	371	380	0.972	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_B	2pul-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	1.710E-06	1.000	187	36	284	284	22	354	369	353	0.877	0.902
LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_A	2pul-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	2.896E-06	1.000	187	6	284	284	6	366	381	388	0.982	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_A	2pun-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	2.346E-06	1.000	186	9	284	284	7	365	380	387	0.972	0.945
LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_B	2pun-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	1.900E-06	1.000	183	17	284	284	11	363	378	376	0.944	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	4wwa-assembly1.cif.gz_A	4wwa-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121	2.473E-06	1.000	182	35	276	284	15	223	224	262	0.852	0.933
LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_A	2pyw-assembly1.cif.gz_A Structure of A. thaliana 5-methylthioribose kinase in complex with ADP and MTR	6.053E-06	1.000	182	7	284	284	5	404	417	417	0.979	0.959
LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	4.903E-06	1.000	178	26	218	284	5	208	212	222	0.680	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_B	2olc-assembly1.cif.gz_B Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	3.392E-06	1.000	178	13	284	284	9	361	376	379	0.958	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly1.cif.gz_A	1zth-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	7.876E-06	1.000	177	9	218	284	29	244	245	233	0.739	0.882
LOKIASV2_0141_ESMFold_hypothetical_protein	1zar-assembly1.cif.gz_A	1zar-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ADP and Manganese Ions	3.392E-06	1.000	177	15	217	284	76	266	267	217	0.715	0.715
LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_B	2pui-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	1.025E-05	1.000	174	9	274	284	5	342	367	369	0.937	0.921
LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A	2pu8-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	3.972E-06	1.000	174	35	284	284	17	358	373	359	0.880	0.917
LOKIASV2_0141_ESMFold_hypothetical_protein	6sul-assembly2.cif.gz_D	6sul-assembly2.cif.gz_D Amicoumacin kinase AmiN in complex with AMP-PNP, Mg2+ and Ami	3.052E-06	1.000	171	13	274	284	6	318	334	343	0.923	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_A	2olc-assembly1.cif.gz_A Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	4.652E-06	1.000	170	6	274	284	6	351	376	377	0.947	0.920
LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_B	2pu8-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	7.876E-06	1.000	169	35	284	284	21	350	365	357	0.880	0.904
LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_A	2pui-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	1.139E-05	1.000	167	35	284	284	19	353	368	354	0.880	0.910
LOKIASV2_0141_ESMFold_hypothetical_protein	1zao-assembly1.cif.gz_A	1zao-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ATP and Manganese Ions	8.302E-06	1.000	166	15	218	284	77	270	271	217	0.718	0.716
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly4.cif.gz_D	1zth-assembly4.cif.gz_D Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	1.334E-05	1.000	165	12	217	284	34	243	244	228	0.725	0.861
LOKIASV2_0141_ESMFold_hypothetical_protein	4f99-assembly1.cif.gz_A	4f99-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	1.200E-05	1.000	165	13	181	284	2	164	312	181	0.595	0.522
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_A	6fdn-assembly1.cif.gz_A Rio2 structure	3.823E-05	1.000	164	14	196	284	42	214	232	191	0.644	0.746
LOKIASV2_0141_ESMFold_hypothetical_protein	1ztf-assembly1.cif.gz_A	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	7.876E-06	1.000	164	5	217	284	13	252	253	251	0.750	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly3.cif.gz_C	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	1.735E-05	1.000	163	12	218	284	34	240	241	222	0.729	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	2.111E-06	1.000	162	14	275	284	4	294	296	341	0.923	0.983
LOKIASV2_0141_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	6.824E-05	1.000	161	29	181	284	14	169	367	171	0.539	0.425
LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly1.cif.gz_A	3re4-assembly1.cif.gz_A Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	2.032E-05	1.000	160	17	218	284	35	251	252	230	0.711	0.861
LOKIASV2_0141_ESMFold_hypothetical_protein	2j5f-assembly1.cif.gz_A	2j5f-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jab	3.768E-06	1.000	160	28	219	284	16	207	308	210	0.676	0.623
LOKIASV2_0141_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	7.876E-06	1.000	159	25	218	284	6	192	273	208	0.683	0.685
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_B	6fdn-assembly1.cif.gz_B Rio2 structure	6.474E-05	1.000	158	19	196	284	69	234	252	185	0.627	0.659
LOKIASV2_0141_ESMFold_hypothetical_protein	3ad6-assembly1.cif.gz_A	3ad6-assembly1.cif.gz_A Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)	2.258E-05	1.000	158	26	181	284	13	161	273	167	0.549	0.546
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	4.413E-06	1.000	158	28	223	284	15	212	280	217	0.690	0.707
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_D	6fdm-assembly2.cif.gz_D Human Rio2 kinase structure	7.089E-06	1.000	158	12	218	284	66	278	283	232	0.729	0.753
LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly2.cif.gz_B	3re4-assembly2.cif.gz_B Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	3.265E-05	1.000	157	17	216	284	35	246	249	225	0.704	0.851
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly2.cif.gz_B	6fdo-assembly2.cif.gz_B Rio2 structure	1.562E-05	1.000	157	12	218	284	65	280	284	232	0.729	0.761
LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_A	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	9.723E-06	1.000	157	12	218	284	74	289	300	234	0.729	0.720
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly2.cif.gz_B	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	5.168E-06	1.000	156	7	218	284	27	240	241	234	0.746	0.888
LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	1.928E-05	1.000	156	21	213	284	6	186	267	202	0.680	0.678
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_C	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	1.928E-05	1.000	154	12	218	284	70	281	285	231	0.729	0.744
LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_B	2pup-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	4.720E-05	1.000	154	17	274	284	7	345	370	365	0.908	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_G	6hk6-assembly4.cif.gz_G Human RIOK2 bound to inhibitor	6.142E-05	1.000	153	14	202	284	69	245	271	198	0.665	0.653
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly5.cif.gz_H	6hk6-assembly5.cif.gz_H Human RIOK2 bound to inhibitor	4.975E-05	1.000	153	12	202	284	75	255	282	199	0.673	0.642
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	1.482E-05	1.000	153	13	271	284	7	282	284	325	0.912	0.972
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	2.142E-05	1.000	153	13	242	284	7	264	297	299	0.810	0.869
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	9.723E-06	1.000	152	28	220	284	14	211	276	217	0.680	0.717
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_A	6fdm-assembly1.cif.gz_A Human Rio2 kinase structure	4.030E-05	1.000	152	12	218	284	70	282	286	234	0.729	0.745
LOKIASV2_0141_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	2.509E-05	1.000	152	20	272	284	4	285	290	326	0.891	0.972
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	1.406E-05	1.000	152	13	273	284	7	288	296	330	0.919	0.953
LOKIASV2_0141_ESMFold_hypothetical_protein	2ity-assembly1.cif.gz_A	2ity-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with Iressa	7.472E-06	1.000	152	28	233	284	15	259	300	257	0.725	0.817
LOKIASV2_0141_ESMFold_hypothetical_protein	5uxa-assembly1.cif.gz_A	5uxa-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphB from Escherichia coli	6.053E-06	1.000	152	13	272	284	2	297	301	343	0.915	0.983
LOKIASV2_0141_ESMFold_hypothetical_protein	4yju-assembly1.cif.gz_A	4yju-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249	2.346E-06	1.000	151	28	269	284	6	240	267	273	0.852	0.880
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjt-assembly1.cif.gz_A	4yjt-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233	8.751E-06	1.000	151	28	220	284	6	246	270	253	0.680	0.893
LOKIASV2_0141_ESMFold_hypothetical_protein	4g2f-assembly1.cif.gz_A	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	3.218E-06	1.000	151	28	282	284	12	264	275	298	0.898	0.920
LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly1.cif.gz_A	5mjb-assembly1.cif.gz_A Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	1.562E-05	1.000	151	28	196	284	11	204	278	210	0.595	0.698
LOKIASV2_0141_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	1.426E-04	1.000	150	28	181	284	5	152	261	166	0.542	0.567
LOKIASV2_0141_ESMFold_hypothetical_protein	5cy3-assembly1.cif.gz_A	5cy3-assembly1.cif.gz_A SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor	1.623E-06	1.000	150	28	281	284	10	275	276	299	0.894	0.964
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn5-assembly2.cif.gz_B	3kn5-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of msk1 in complex with AMP-PNP	8.879E-05	1.000	150	25	205	284	6	180	289	195	0.637	0.606
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_B	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	3.097E-05	1.000	149	12	218	284	64	275	280	231	0.729	0.757
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	2.174E-04	1.000	149	28	181	284	24	178	339	170	0.542	0.457
LOKIASV2_0141_ESMFold_hypothetical_protein	4ix3-assembly1.cif.gz_A	4ix3-assembly1.cif.gz_A Crystal structure of a Stt7 homolog from Micromonas algae	1.426E-04	1.000	149	28	177	284	20	192	346	186	0.528	0.500
LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	1.284E-04	1.000	148	29	193	284	9	187	233	193	0.581	0.768
LOKIASV2_0141_ESMFold_hypothetical_protein	4li5-assembly1.cif.gz_A	4li5-assembly1.cif.gz_A EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide	9.224E-06	1.000	148	28	239	284	19	279	306	275	0.746	0.853
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	2.346E-06	1.000	147	28	269	284	14	244	271	265	0.852	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg6-assembly1.cif.gz_A	4xg6-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	1.539E-06	1.000	147	28	280	284	7	270	271	296	0.891	0.974
LOKIASV2_0141_ESMFold_hypothetical_protein	4e20-assembly1.cif.gz_A	4e20-assembly1.cif.gz_A Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor	3.052E-06	1.000	147	34	271	284	8	257	282	267	0.838	0.887
LOKIASV2_0141_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	8.183E-07	1.000	147	31	284	284	4	267	283	293	0.894	0.933
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	6.380E-06	1.000	147	28	238	284	13	239	285	247	0.743	0.796
LOKIASV2_0141_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	6.142E-05	1.000	147	25	205	284	6	178	286	191	0.637	0.605
LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly1.cif.gz_A	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	2.645E-05	1.000	146	28	220	284	8	202	267	217	0.680	0.730
LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	2.142E-05	1.000	146	28	220	284	8	208	272	222	0.680	0.739
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	4.903E-06	1.000	146	28	238	284	14	233	279	235	0.743	0.789
LOKIASV2_0141_ESMFold_hypothetical_protein	5gmp-assembly1.cif.gz_A	5gmp-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with XTF-262	5.448E-06	1.000	146	31	227	284	12	206	305	215	0.694	0.639
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg7-assembly1.cif.gz_A	4xg7-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	5.168E-06	1.000	145	31	280	284	2	265	266	312	0.880	0.992
LOKIASV2_0141_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	1.460E-06	1.000	145	31	282	284	4	261	272	286	0.887	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly1.cif.gz_A	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	2.788E-05	1.000	145	25	206	284	6	197	273	212	0.641	0.703
LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_B	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	4.478E-05	1.000	145	12	218	284	70	281	286	232	0.729	0.741
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_J	6hk6-assembly4.cif.gz_J Human RIOK2 bound to inhibitor	9.865E-05	1.000	145	14	202	284	78	264	290	208	0.665	0.645
LOKIASV2_0141_ESMFold_hypothetical_protein	7vnx-assembly1.cif.gz_A	7vnx-assembly1.cif.gz_A Crystal structure of TkArkI	2.938E-05	1.000	144	1	269	284	1	214	216	281	0.947	0.991
LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	7.992E-05	1.000	144	26	234	284	5	236	241	246	0.736	0.963
LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_B	2pyw-assembly1.cif.gz_B Structure of A. thaliana 5-methylthioribose kinase in complex with ADP and MTR	2.938E-05	1.000	144	7	274	284	6	343	411	377	0.944	0.822
LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	2.938E-05	1.000	143	22	225	284	9	245	247	257	0.718	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	3.575E-06	1.000	143	17	277	284	2	272	273	298	0.919	0.993
LOKIASV2_0141_ESMFold_hypothetical_protein	4p5q-assembly1.cif.gz_A	4p5q-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	3.972E-06	1.000	143	31	284	284	8	266	275	300	0.894	0.942
LOKIASV2_0141_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	3.052E-06	1.000	143	28	278	284	13	284	285	298	0.884	0.954
LOKIASV2_0141_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B	6g3c-assembly2.cif.gz_B Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2	2.226E-06	1.000	142	28	234	284	8	246	268	256	0.729	0.892
LOKIASV2_0141_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A	3lm5-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin	8.751E-06	1.000	142	22	273	284	8	241	274	273	0.887	0.854
LOKIASV2_0141_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	1.829E-05	1.000	142	28	226	284	9	214	274	222	0.701	0.752
LOKIASV2_0141_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	7.472E-06	1.000	142	23	250	284	4	276	277	289	0.803	0.986
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	3.218E-06	1.000	142	28	274	284	14	273	279	284	0.870	0.932
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	3.768E-06	1.000	142	28	274	284	16	277	281	290	0.870	0.932
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6w-assembly1.cif.gz_L	5l6w-assembly1.cif.gz_L Structure Of the LIMK1-ATPgammaS-CFL1 Complex	3.823E-05	1.000	142	28	275	284	11	289	290	314	0.873	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A	7uyw-assembly1.cif.gz_A Crystal structure of JAK2 kinase domain in complex with compound 30	3.052E-06	1.000	142	34	274	284	6	285	290	312	0.849	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	4.903E-06	1.000	141	28	271	284	14	256	278	279	0.859	0.874
LOKIASV2_0141_ESMFold_hypothetical_protein	5i9v-assembly1.cif.gz_A	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	1.482E-05	1.000	141	31	220	284	4	197	279	213	0.669	0.695
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A	7ju5-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with pralsetinib	2.747E-06	1.000	141	28	278	284	24	286	287	291	0.884	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	5.168E-06	1.000	141	28	271	284	14	263	287	283	0.859	0.871
LOKIASV2_0141_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	8.751E-06	1.000	141	13	238	284	3	298	299	319	0.796	0.990
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	4.975E-05	1.000	140	35	215	284	2	215	261	228	0.637	0.820
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjp-assembly1.cif.gz_A	4yjp-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223	5.168E-06	1.000	140	28	276	284	6	262	263	298	0.877	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg9-assembly2.cif.gz_B	4xg9-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	4.187E-06	1.000	140	28	278	284	7	264	265	293	0.884	0.974
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	7.582E-05	1.000	140	35	213	284	1	172	276	197	0.630	0.623
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.735E-05	1.000	140	28	238	284	13	235	281	239	0.743	0.794
LOKIASV2_0141_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	2.896E-06	1.000	140	11	274	284	3	280	283	304	0.930	0.982
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly1.cif.gz_A	6fdo-assembly1.cif.gz_A Rio2 structure	8.879E-05	1.000	140	12	218	284	66	281	286	228	0.729	0.755
LOKIASV2_0141_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B	3b2t-assembly1.cif.gz_B Structure of phosphotransferase	5.743E-06	1.000	140	29	241	284	17	285	287	284	0.750	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	1.585E-04	1.000	140	34	181	284	2	152	289	165	0.521	0.522
LOKIASV2_0141_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	9.723E-06	1.000	140	13	235	284	2	292	296	319	0.785	0.983
LOKIASV2_0141_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A	5x27-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)	4.903E-06	1.000	140	28	280	284	15	270	302	292	0.891	0.848
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly6.cif.gz_F	7jxh-assembly6.cif.gz_F HER2 in complex with JBJ-08-178-01	1.829E-05	1.000	139	28	220	284	7	190	262	210	0.680	0.702
LOKIASV2_0141_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A	7q7c-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ADP at atmospheric pressure	8.751E-06	1.000	139	22	277	284	8	264	272	295	0.901	0.945
LOKIASV2_0141_ESMFold_hypothetical_protein	4gk3-assembly1.cif.gz_A	4gk3-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 87	5.448E-06	1.000	139	28	277	284	12	263	275	284	0.880	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	3.392E-06	1.000	139	28	277	284	12	288	289	300	0.880	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	4.652E-06	1.000	139	13	271	284	7	289	299	328	0.912	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	2itz-assembly1.cif.gz_A	2itz-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with Iressa	4.187E-06	1.000	139	28	274	284	15	262	302	279	0.870	0.821
LOKIASV2_0141_ESMFold_hypothetical_protein	4rss-assembly1.cif.gz_A	4rss-assembly1.cif.gz_A Crystal structure of tyrosine-protein kinase SYK with an inhibitor	6.053E-06	1.000	138	28	278	284	6	268	269	294	0.884	0.978
LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	6.380E-06	1.000	138	28	272	284	12	267	269	281	0.863	0.952
LOKIASV2_0141_ESMFold_hypothetical_protein	5uir-assembly1.cif.gz_A	5uir-assembly1.cif.gz_A Crystal structure of IRAK4 in complex with compound 11	1.406E-05	1.000	138	8	274	284	6	271	272	312	0.940	0.978
LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_A	2pz5-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	1.482E-05	1.000	138	34	241	284	12	276	280	280	0.732	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly2.cif.gz_B	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	8.751E-06	1.000	138	25	280	284	6	285	286	300	0.901	0.979
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A	6lvm-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	2.473E-06	1.000	138	28	277	284	12	287	288	295	0.880	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	1.265E-05	1.000	138	28	239	284	13	284	290	284	0.746	0.938
LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E	4lrm-assembly5.cif.gz_E EGFR D770_N771insNPG in complex with PD168393	7.472E-06	1.000	138	28	274	284	15	278	290	295	0.870	0.910
LOKIASV2_0141_ESMFold_hypothetical_protein	6zxf-assembly1.cif.gz_z	6zxf-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State G	8.424E-05	1.000	138	1	269	284	21	297	373	310	0.947	0.743
LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	4.975E-05	1.000	137	35	220	284	2	229	249	242	0.655	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	2.509E-05	1.000	137	35	227	284	3	209	262	225	0.680	0.790
LOKIASV2_0141_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	7.876E-06	1.000	137	28	277	284	23	288	289	292	0.880	0.920
LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly2.cif.gz_A	4ll0-assembly2.cif.gz_A EGFR L858R/T790M in complex with PD168393	1.334E-05	1.000	137	28	239	284	15	262	291	263	0.746	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	3fi8-assembly1.cif.gz_A	3fi8-assembly1.cif.gz_A Crystal structure of choline kinase from Plasmodium Falciparum, PF14_0020	1.562E-05	1.000	137	32	281	284	24	338	339	336	0.880	0.929
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly2.cif.gz_B	4d4v-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain	1.139E-05	1.000	136	28	278	284	7	252	255	281	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	3.441E-05	1.000	136	6	224	284	1	259	262	301	0.771	0.989
LOKIASV2_0141_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	1.025E-05	1.000	136	28	274	284	9	252	273	275	0.870	0.894
LOKIASV2_0141_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	4.903E-06	1.000	136	34	275	284	7	273	275	297	0.852	0.971
LOKIASV2_0141_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A	3lm0-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B)	1.406E-05	1.000	136	22	274	284	8	247	278	278	0.891	0.863
LOKIASV2_0141_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	6.380E-06	1.000	136	17	277	284	2	278	279	302	0.919	0.993
LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	5.448E-06	1.000	136	28	274	284	12	278	282	300	0.870	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	3bce-assembly3.cif.gz_C	3bce-assembly3.cif.gz_C Crystal structure of the ErbB4 kinase	2.258E-05	1.000	136	28	253	284	15	279	286	287	0.796	0.927
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	7.876E-06	1.000	136	28	274	284	15	260	286	278	0.870	0.860
LOKIASV2_0141_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	2.683E-04	1.000	136	28	179	284	6	155	287	165	0.535	0.523
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly2.cif.gz_F	6hk6-assembly2.cif.gz_F Human RIOK2 bound to inhibitor	4.248E-05	1.000	136	14	223	284	77	260	289	227	0.739	0.637
LOKIASV2_0141_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	3.627E-05	1.000	136	8	234	284	3	224	326	264	0.799	0.681
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	5.168E-06	1.000	135	28	274	284	14	267	271	286	0.870	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	6x8f-assembly1.cif.gz_A	6x8f-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 11	1.928E-05	1.000	135	38	271	284	15	257	283	273	0.824	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	9.723E-06	1.000	135	28	271	284	13	261	286	289	0.859	0.871
LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	7.472E-06	1.000	135	28	280	284	14	287	288	300	0.891	0.951
LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly1.cif.gz_A	4lrm-assembly1.cif.gz_A EGFR D770_N771insNPG in complex with PD168393	2.938E-05	1.000	135	28	227	284	16	220	307	228	0.704	0.668
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjv-assembly1.cif.gz_A	4yjv-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250	2.032E-05	1.000	134	31	220	284	2	241	265	251	0.669	0.906
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	1.080E-05	1.000	134	28	282	284	8	261	266	292	0.898	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B	4j95-assembly5.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	2.142E-05	1.000	134	28	241	284	13	280	282	281	0.754	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	6o95-assembly3.cif.gz_C	6o95-assembly3.cif.gz_C Structure of the IRAK4 kinase domain with compound 41	1.928E-05	1.000	134	10	274	284	8	285	286	331	0.933	0.972
LOKIASV2_0141_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	2.415E-04	1.000	134	34	181	284	2	148	288	161	0.521	0.510
LOKIASV2_0141_ESMFold_hypothetical_protein	8wtf-assembly1.cif.gz_A	8wtf-assembly1.cif.gz_A The Crystal Structure of IRAK4 from Biortus	1.025E-05	1.000	134	12	274	284	10	290	291	331	0.926	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	6zxd-assembly1.cif.gz_z	6zxd-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F1	7.193E-05	1.000	134	4	266	284	22	290	292	295	0.926	0.921
LOKIASV2_0141_ESMFold_hypothetical_protein	5nk0-assembly1.cif.gz_A	5nk0-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1j	3.441E-05	1.000	133	31	220	284	7	194	273	210	0.669	0.689
LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_A	2py3-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	2.509E-05	1.000	133	34	241	284	12	278	282	281	0.732	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	5.743E-06	1.000	133	17	275	284	2	288	289	321	0.912	0.993
LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_B	3mes-assembly1.cif.gz_B Crystal structure of choline kinase from Cryptosporidium parvum Iowa II, cgd3_2030	2.938E-05	1.000	133	16	280	284	2	343	358	371	0.933	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	2.062E-04	1.000	132	26	236	284	7	238	242	247	0.743	0.959
LOKIASV2_0141_ESMFold_hypothetical_protein	4d55-assembly1.cif.gz_A	4d55-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain	3.265E-05	1.000	132	28	278	284	9	258	260	285	0.884	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	7.992E-05	1.000	132	28	218	284	10	233	262	242	0.673	0.855
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly1.cif.gz_A	6yvy-assembly1.cif.gz_A FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	9.224E-06	1.000	132	28	280	284	10	264	265	287	0.891	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A	8c09-assembly1.cif.gz_A Crystal structure of JAK2 JH2-I559F	1.562E-05	1.000	132	34	274	284	6	271	272	287	0.849	0.978
LOKIASV2_0141_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	4.720E-05	1.000	132	34	218	284	7	235	281	242	0.651	0.815
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2m-assembly1.cif.gz_A	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	8.302E-06	1.000	132	20	278	284	3	286	287	310	0.912	0.990
LOKIASV2_0141_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	3.441E-05	1.000	132	34	227	284	8	243	288	248	0.683	0.819
LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	1.562E-05	1.000	132	28	279	284	20	301	302	306	0.887	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A	3kxx-assembly1.cif.gz_A Structure of the mutant Fibroblast Growth Factor receptor 1	3.265E-05	1.000	132	28	251	284	17	301	305	305	0.789	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	2.258E-05	1.000	131	35	220	284	2	191	236	213	0.655	0.805
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0m-assembly1.cif.gz_B	2j0m-assembly1.cif.gz_B Crystal structure a two-chain complex between the FERM and kinase domains of focal adhesion kinase.	2.258E-05	1.000	131	28	278	284	8	254	257	283	0.884	0.961
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzt-assembly1.cif.gz_A	3fzt-assembly1.cif.gz_A Crystal structure of PYK2 complexed with PF-4618433	7.876E-06	1.000	131	26	280	284	3	257	259	278	0.898	0.985
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	6.474E-05	1.000	131	35	234	284	2	216	277	230	0.704	0.776
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	7.992E-05	1.000	131	28	220	284	21	213	277	212	0.680	0.697
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.482E-05	1.000	131	28	274	284	14	259	284	281	0.870	0.866
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.025E-05	1.000	131	28	274	284	14	294	298	307	0.870	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	3q6w-assembly1.cif.gz_A	3q6w-assembly1.cif.gz_A Structure of dually-phosphorylated MET receptor kinase in complex with an MK-2461 analog with specificity for the activated receptor	4.720E-05	1.000	131	2	241	284	4	289	299	302	0.845	0.957
LOKIASV2_0141_ESMFold_hypothetical_protein	3c5i-assembly1.cif.gz_A	3c5i-assembly1.cif.gz_A Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520	2.938E-05	1.000	131	11	284	284	11	339	343	358	0.965	0.959
LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_A	3mes-assembly1.cif.gz_A Crystal structure of choline kinase from Cryptosporidium parvum Iowa II, cgd3_2030	3.265E-05	1.000	131	16	283	284	2	341	357	372	0.944	0.952
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi1-assembly1.cif.gz_A	4bi1-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.032E-05	1.000	130	29	271	284	10	230	252	259	0.856	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	3tud-assembly1.cif.gz_A	3tud-assembly1.cif.gz_A Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide	1.265E-05	1.000	130	28	274	284	7	228	256	267	0.870	0.867
LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A	2pwl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	1.265E-05	1.000	130	28	274	284	14	280	284	299	0.870	0.940
LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	1.646E-05	1.000	130	28	271	284	22	263	288	277	0.859	0.840
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2	2x2l-assembly1.cif.gz_A-2 Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	1.025E-05	1.000	130	28	274	284	22	286	288	291	0.870	0.920
LOKIASV2_0141_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	1.406E-05	1.000	130	28	274	284	15	264	291	286	0.870	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly1.cif.gz_A	5flf-assembly1.cif.gz_A DISEASE LINKED MUTATION IN FGFR	1.829E-05	1.000	130	28	271	284	18	271	296	289	0.859	0.858
LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly2.cif.gz_D	4riy-assembly2.cif.gz_D Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	1.928E-05	1.000	130	28	273	284	24	287	297	292	0.866	0.889
LOKIASV2_0141_ESMFold_hypothetical_protein	3ika-assembly3.cif.gz_A	3ika-assembly3.cif.gz_A Crystal Structure of EGFR 696-1022 T790M Mutant Covalently Binding to WZ4002	2.032E-05	1.000	130	28	273	284	16	279	310	291	0.866	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly4.cif.gz_D	6yvy-assembly4.cif.gz_D FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	2.747E-06	1.000	129	28	280	284	7	254	255	284	0.891	0.973
LOKIASV2_0141_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	1.646E-05	1.000	129	34	273	284	7	240	259	274	0.845	0.903
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzr-assembly1.cif.gz_A	3fzr-assembly1.cif.gz_A Crystal structure of PYK2 complexed with PF-431396	1.829E-05	1.000	129	28	280	284	6	258	261	281	0.891	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A	6xjk-assembly1.cif.gz_A JAK2 JH2 in complex with JAK067	4.903E-06	1.000	129	28	272	284	6	264	265	297	0.863	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	1.139E-05	1.000	129	31	282	284	4	259	265	290	0.887	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	2.142E-05	1.000	129	28	278	284	9	268	270	299	0.884	0.963
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A	6nvl-assembly1.cif.gz_A FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	3.441E-05	1.000	129	28	220	284	8	212	280	220	0.680	0.732
LOKIASV2_0141_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A	7q7d-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ATP/ADP at 111 MPa helium gas pressure in a sapphire capillary	4.248E-05	1.000	129	22	277	284	8	272	280	299	0.901	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	4.720E-05	1.000	129	28	241	284	13	280	282	283	0.754	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	1.562E-05	1.000	129	28	274	284	14	287	291	294	0.870	0.942
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	1.406E-05	1.000	129	28	271	284	14	265	291	286	0.859	0.866
LOKIASV2_0141_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	2.509E-05	1.000	129	34	274	284	7	286	291	314	0.849	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	1.646E-05	1.000	129	28	279	284	20	300	301	309	0.887	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	1.735E-05	1.000	128	35	274	284	2	248	256	283	0.845	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly5.cif.gz_E	7jxh-assembly5.cif.gz_E HER2 in complex with JBJ-08-178-01	1.735E-05	1.000	128	34	274	284	10	259	268	271	0.849	0.933
LOKIASV2_0141_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	1.482E-05	1.000	128	30	274	284	4	273	274	288	0.863	0.985
LOKIASV2_0141_ESMFold_hypothetical_protein	7dua-assembly1.cif.gz_B	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	2.258E-05	1.000	128	28	277	284	21	273	274	283	0.880	0.923
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly1.cif.gz_A	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	3.823E-05	1.000	128	25	250	284	6	277	282	289	0.796	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.829E-05	1.000	128	28	274	284	14	260	285	283	0.870	0.867
LOKIASV2_0141_ESMFold_hypothetical_protein	5usy-assembly2.cif.gz_B	5usy-assembly2.cif.gz_B JAK2 JH1 in complex with JNJ-7706621	4.030E-05	1.000	128	34	274	284	8	284	288	312	0.849	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	6.824E-05	1.000	128	9	276	284	1	295	296	338	0.944	0.997
LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_D	3f5p-assembly17.cif.gz_D Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	4.720E-05	1.000	128	34	238	284	18	282	300	274	0.722	0.883
LOKIASV2_0141_ESMFold_hypothetical_protein	4g5p-assembly3.cif.gz_B	4g5p-assembly3.cif.gz_B Crystal structure of EGFR kinase T790M in complex with BIBW2992	5.827E-05	1.000	128	28	239	284	15	267	303	267	0.746	0.835
LOKIASV2_0141_ESMFold_hypothetical_protein	2itu-assembly1.cif.gz_A	2itu-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941	1.406E-05	1.000	128	28	274	284	16	270	304	275	0.870	0.839
LOKIASV2_0141_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A	3gqi-assembly1.cif.gz_A Crystal Structure of activated receptor tyrosine kinase in complex with substrates	2.258E-05	1.000	128	28	274	284	14	273	307	291	0.870	0.847
LOKIASV2_0141_ESMFold_hypothetical_protein	7wu0-assembly1.cif.gz_v	7wu0-assembly1.cif.gz_v Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-B3	8.879E-05	1.000	128	12	238	284	69	315	324	268	0.799	0.762
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	2.032E-05	1.000	127	36	271	284	10	235	257	255	0.831	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C	3gql-assembly3.cif.gz_C Crystal Structure of activated receptor tyrosine kinase in complex with substrates	3.265E-05	1.000	127	28	241	284	15	268	275	270	0.754	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	2.788E-05	1.000	127	28	274	284	14	273	277	281	0.870	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	4un0-assembly2.cif.gz_D	4un0-assembly2.cif.gz_D Crystal structure of the human CDK12-cyclinK complex	5.528E-05	1.000	127	28	215	284	4	200	277	220	0.662	0.711
LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly3.cif.gz_B	4ll0-assembly3.cif.gz_B EGFR L858R/T790M in complex with PD168393	4.478E-05	1.000	127	28	228	284	14	266	281	269	0.708	0.900
LOKIASV2_0141_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	2.062E-04	1.000	127	18	190	284	2	177	407	198	0.609	0.432
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	6.142E-05	1.000	126	35	227	284	2	207	260	227	0.680	0.792
LOKIASV2_0141_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A	4gk2-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 66	2.032E-05	1.000	126	28	274	284	12	254	265	277	0.870	0.917
LOKIASV2_0141_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	9.865E-05	1.000	126	28	216	284	7	220	269	230	0.665	0.796
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly3.cif.gz_C	6fnh-assembly3.cif.gz_C Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	3.097E-05	1.000	126	32	236	284	10	212	270	225	0.722	0.752
LOKIASV2_0141_ESMFold_hypothetical_protein	5mja-assembly2.cif.gz_B	5mja-assembly2.cif.gz_B Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	9.224E-06	1.000	126	28	274	284	10	267	276	298	0.870	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	1.928E-05	1.000	126	28	274	284	18	285	292	287	0.870	0.918
LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_K-2	3f5p-assembly17.cif.gz_K-2 Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	4.248E-05	1.000	126	9	238	284	2	279	296	294	0.810	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A	5eg3-assembly1.cif.gz_A Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)	3.097E-05	1.000	126	28	284	284	15	298	302	311	0.905	0.940
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap5-assembly1.cif.gz_A	5ap5-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	2.380E-05	1.000	125	36	271	284	11	230	252	251	0.831	0.873
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzs-assembly1.cif.gz_A	3fzs-assembly1.cif.gz_A Crystal Structure of PYK2 complexed with BIRB796	1.482E-05	1.000	125	28	280	284	5	252	254	274	0.891	0.976
LOKIASV2_0141_ESMFold_hypothetical_protein	4p5z-assembly1.cif.gz_A	4p5z-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	3.441E-05	1.000	125	28	282	284	12	258	267	292	0.898	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvi-assembly1.cif.gz_A	6nvi-assembly1.cif.gz_A FGFR4 complex with N-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide	1.200E-05	1.000	125	28	277	284	14	269	270	288	0.880	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	6.824E-05	1.000	125	28	235	284	15	264	276	262	0.732	0.906
LOKIASV2_0141_ESMFold_hypothetical_protein	6ny4-assembly1.cif.gz_A	6ny4-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor	6.474E-05	1.000	125	34	232	284	6	276	277	282	0.701	0.978
LOKIASV2_0141_ESMFold_hypothetical_protein	5k72-assembly3.cif.gz_C	5k72-assembly3.cif.gz_C IRAK4 in complex with Compound 21	5.827E-05	1.000	125	40	274	284	31	278	279	295	0.827	0.889
LOKIASV2_0141_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	2.938E-05	1.000	125	28	278	284	13	286	287	302	0.884	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A	7vdp-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	6.924E-04	1.000	125	42	181	284	1	148	287	162	0.493	0.516
LOKIASV2_0141_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	2.032E-05	1.000	125	28	274	284	13	289	293	295	0.870	0.945
LOKIASV2_0141_ESMFold_hypothetical_protein	4kao-assembly1.cif.gz_A	4kao-assembly1.cif.gz_A FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea	2.788E-05	1.000	124	26	280	284	5	251	252	287	0.898	0.980
LOKIASV2_0141_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	8.879E-05	1.000	124	29	234	284	11	206	254	224	0.725	0.772
LOKIASV2_0141_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A	7mu7-assembly1.cif.gz_A Ask1 bound to compound 3	2.938E-05	1.000	124	35	284	284	2	263	263	297	0.880	0.996
LOKIASV2_0141_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A	6bss-assembly1.cif.gz_A JAK2 JH2 in complex with NU6102	2.645E-05	1.000	124	28	274	284	8	250	271	276	0.870	0.897
LOKIASV2_0141_ESMFold_hypothetical_protein	3eqr-assembly3.cif.gz_B	3eqr-assembly3.cif.gz_B Crystal Structure of Ack1 with compound T74	4.030E-05	1.000	124	31	273	284	5	268	271	290	0.856	0.974
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B	8h75-assembly1.cif.gz_B FGFR2 in complex with YJ001	2.258E-05	1.000	124	34	274	284	13	279	283	298	0.849	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	5wal-assembly1.cif.gz_A	5wal-assembly1.cif.gz_A Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model	3.823E-05	1.000	124	38	271	284	7	261	286	275	0.824	0.892
LOKIASV2_0141_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	2.032E-05	1.000	124	28	274	284	17	289	294	305	0.870	0.929
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly1.cif.gz_A	2j0k-assembly1.cif.gz_A Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	1.503E-04	1.000	124	28	236	284	348	595	598	265	0.736	0.415
LOKIASV2_0141_ESMFold_hypothetical_protein	5ljj-assembly1.cif.gz_A	5ljj-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Reversine	4.030E-05	1.000	123	38	271	284	17	241	264	255	0.824	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly2.cif.gz_B	5mjb-assembly2.cif.gz_B Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	1.265E-05	1.000	123	28	274	284	11	271	280	299	0.870	0.932
LOKIASV2_0141_ESMFold_hypothetical_protein	4zjv-assembly1.cif.gz_A	4zjv-assembly1.cif.gz_A crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein	1.829E-05	1.000	123	28	274	284	9	268	282	297	0.870	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A	7du9-assembly1.cif.gz_A Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	4.248E-05	1.000	123	26	274	284	8	282	285	303	0.877	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	2.509E-05	1.000	123	28	278	284	13	285	286	288	0.884	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly2.cif.gz_B	3kn6-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of MSK1	9.359E-05	1.000	123	25	281	284	6	287	288	310	0.905	0.979
LOKIASV2_0141_ESMFold_hypothetical_protein	3cly-assembly1.cif.gz_A	3cly-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction	1.562E-05	1.000	123	28	278	284	13	284	291	294	0.884	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A	1pkg-assembly1.cif.gz_A Structure of a c-Kit Kinase Product Complex	4.975E-05	1.000	123	32	273	284	19	291	292	299	0.852	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	6jrx-assembly1.cif.gz_A	6jrx-assembly1.cif.gz_A EGFR T790M/C797S in complex with compound 6i	2.258E-05	1.000	123	28	274	284	16	273	300	291	0.870	0.860
LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	5.528E-05	1.000	123	28	271	284	19	279	304	298	0.859	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0j-assembly1.cif.gz_A	2j0j-assembly1.cif.gz_A Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	6.380E-06	1.000	123	28	278	284	356	608	611	290	0.884	0.414
LOKIASV2_0141_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A	4p4c-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	2.938E-05	1.000	122	31	282	284	4	254	266	296	0.887	0.944
LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly4.cif.gz_D	7lg8-assembly4.cif.gz_D EGFR (T79M/V948R) in complex with naquotinib and an allosteric inhibitor	1.040E-04	1.000	122	28	220	284	10	193	271	210	0.680	0.679
LOKIASV2_0141_ESMFold_hypothetical_protein	7pcd-assembly1.cif.gz_A	7pcd-assembly1.cif.gz_A HER2 IN COMPLEX WITH A COVALENT INHIBITOR	1.829E-05	1.000	122	34	274	284	9	260	272	277	0.849	0.926
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly1.cif.gz_B	7jxh-assembly1.cif.gz_B HER2 in complex with JBJ-08-178-01	3.265E-05	1.000	122	28	274	284	13	263	276	284	0.870	0.909
LOKIASV2_0141_ESMFold_hypothetical_protein	5i9u-assembly1.cif.gz_A	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	1.406E-05	1.000	122	32	260	284	9	273	281	288	0.806	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	3.441E-05	1.000	122	29	279	284	7	281	282	299	0.884	0.975
LOKIASV2_0141_ESMFold_hypothetical_protein	4e1z-assembly1.cif.gz_A	4e1z-assembly1.cif.gz_A Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor	3.441E-05	1.000	122	34	271	284	9	263	288	280	0.838	0.885
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	2.380E-05	1.000	122	11	278	284	3	289	290	312	0.944	0.990
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	2.938E-05	1.000	122	28	277	284	24	290	291	295	0.880	0.918
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly2.cif.gz_A	5ugx-assembly2.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	4.720E-05	1.000	122	28	274	284	13	293	297	302	0.870	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	3w2r-assembly1.cif.gz_A	3w2r-assembly1.cif.gz_A EGFR Kinase domain T790M/L858R mutant with compound 4	3.441E-05	1.000	122	28	274	284	14	264	297	277	0.870	0.845
LOKIASV2_0141_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A	1gag-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR	8.424E-05	1.000	122	34	209	284	14	226	303	225	0.620	0.703
LOKIASV2_0141_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A	4xlv-assembly1.cif.gz_A Crystal structure of the activated insulin receptor tyrosine kinase dimer	4.789E-04	1.000	122	32	179	284	19	183	310	172	0.521	0.532
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly7.cif.gz_G	7jxh-assembly7.cif.gz_G HER2 in complex with JBJ-08-178-01	4.248E-05	1.000	121	28	274	284	14	264	273	282	0.870	0.919
LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B	1pkg-assembly2.cif.gz_B Structure of a c-Kit Kinase Product Complex	3.627E-05	1.000	121	26	273	284	14	276	279	292	0.873	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	1.334E-05	1.000	121	28	278	284	14	278	279	307	0.884	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	1.265E-05	1.000	121	28	274	284	17	281	286	300	0.870	0.927
LOKIASV2_0141_ESMFold_hypothetical_protein	7run-assembly1.cif.gz_A	7run-assembly1.cif.gz_A Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor.	4.030E-05	1.000	121	28	271	284	19	263	287	286	0.859	0.854
LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_D	6p8q-assembly2.cif.gz_D EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.	4.248E-05	1.000	121	28	273	284	12	293	296	301	0.866	0.953
LOKIASV2_0141_ESMFold_hypothetical_protein	2ito-assembly1.cif.gz_A	2ito-assembly1.cif.gz_A Crystal structure of EGFR kinase domain G719S mutation in complex with Iressa	2.645E-05	1.000	121	28	274	284	16	267	303	288	0.870	0.832
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	4.975E-05	1.000	121	3	283	284	14	313	321	333	0.989	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	2jkq-assembly1.cif.gz_A	2jkq-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	7.582E-05	1.000	120	28	220	284	8	191	258	210	0.680	0.713
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	2.258E-05	1.000	120	28	274	284	19	276	282	284	0.870	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_A	8h75-assembly1.cif.gz_A FGFR2 in complex with YJ001	2.258E-05	1.000	120	28	274	284	14	280	285	289	0.870	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	3nyx-assembly1.cif.gz_A	3nyx-assembly1.cif.gz_A Non-phosphorylated TYK2 JH1 domain with Quinoline-Thiadiazole-Thiophene Inhibitor	5.048E-04	1.000	120	38	181	284	8	158	287	162	0.507	0.526
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly1.cif.gz_A	6lvl-assembly1.cif.gz_A Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	4.248E-05	1.000	120	28	281	284	13	286	288	309	0.894	0.951
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly3.cif.gz_E	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	1.503E-04	1.000	120	14	223	284	78	260	289	226	0.739	0.633
LOKIASV2_0141_ESMFold_hypothetical_protein	3lcd-assembly1.cif.gz_A	3lcd-assembly1.cif.gz_A Inhibitor Bound to A DFG-In structure of the Kinase Domain of CSF-1R	4.975E-05	1.000	120	28	273	284	24	289	290	297	0.866	0.917
LOKIASV2_0141_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	1.670E-04	1.000	120	16	225	284	4	231	290	254	0.739	0.786
LOKIASV2_0141_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	7.582E-05	1.000	120	28	219	284	5	213	294	232	0.676	0.711
LOKIASV2_0141_ESMFold_hypothetical_protein	4f9b-assembly2.cif.gz_C	4f9b-assembly2.cif.gz_C Human CDC7 kinase in complex with DBF4 and PHA767491	4.720E-05	1.000	120	12	276	284	5	281	316	309	0.933	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	4y12-assembly1.cif.gz_A	4y12-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Mycobacterium tuberculosis in complex with AGS	2.788E-05	1.000	120	28	275	284	68	318	322	280	0.873	0.780
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	7.193E-05	1.000	119	29	271	284	10	226	248	262	0.856	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	4.248E-05	1.000	119	36	271	284	10	232	254	253	0.831	0.878
LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly2.cif.gz_B	4gu9-assembly2.cif.gz_B Focal adhesion kinase catalytic domain in complex with (2-Fluoro-phenyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine	1.482E-05	1.000	119	28	274	284	7	251	255	280	0.870	0.961
LOKIASV2_0141_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	3.097E-05	1.000	119	36	271	284	10	235	258	262	0.831	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap7-assembly1.cif.gz_A	5ap7-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	3.265E-05	1.000	119	36	271	284	17	241	263	257	0.831	0.856
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	6.142E-05	1.000	119	28	277	284	14	270	272	297	0.880	0.945
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A	7ju6-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with selpercatinib	4.975E-05	1.000	119	28	277	284	11	287	288	305	0.880	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly1.cif.gz_B	4riy-assembly1.cif.gz_B Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	4.975E-05	1.000	119	28	283	284	24	282	293	298	0.901	0.884
LOKIASV2_0141_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	3.879E-04	1.000	119	28	215	284	24	235	329	229	0.662	0.644
LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_A	2rio-assembly1.cif.gz_A Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	2.415E-04	1.000	119	28	223	284	8	202	396	220	0.690	0.492
LOKIASV2_0141_ESMFold_hypothetical_protein	5nk8-assembly1.cif.gz_A	5nk8-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f	2.174E-04	1.000	118	31	214	284	4	200	266	211	0.648	0.741
LOKIASV2_0141_ESMFold_hypothetical_protein	4xey-assembly1.cif.gz_A	4xey-assembly1.cif.gz_A Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	2.509E-05	1.000	118	32	278	284	8	266	269	294	0.870	0.963
LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	5.244E-05	1.000	118	28	282	284	9	261	284	287	0.898	0.891
LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	3.823E-05	1.000	118	28	279	284	13	283	284	305	0.887	0.954
LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	3.265E-05	1.000	118	28	274	284	16	277	286	300	0.870	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly2.cif.gz_B	7wcl-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain with Pemigatinib	2.645E-05	1.000	118	28	274	284	22	281	287	289	0.870	0.906
LOKIASV2_0141_ESMFold_hypothetical_protein	6jx0-assembly1.cif.gz_A	6jx0-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by co-crystallization	3.097E-05	1.000	118	34	283	284	10	273	289	299	0.880	0.913
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxi-assembly2.cif.gz_A	7jxi-assembly2.cif.gz_A EGFR kinase (T790M/V948R) in complex with PF-06747775	1.096E-04	1.000	118	28	227	284	12	196	290	213	0.704	0.638
LOKIASV2_0141_ESMFold_hypothetical_protein	1k3a-assembly1.cif.gz_A	1k3a-assembly1.cif.gz_A Structure of the Insulin-like Growth Factor 1 Receptor Kinase	1.040E-04	1.000	118	28	234	284	4	228	291	248	0.729	0.773
LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly1.cif.gz_A	4gu9-assembly1.cif.gz_A Focal adhesion kinase catalytic domain in complex with (2-Fluoro-phenyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine	2.258E-05	1.000	117	28	278	284	8	250	252	285	0.884	0.964
LOKIASV2_0141_ESMFold_hypothetical_protein	3tub-assembly1.cif.gz_A	3tub-assembly1.cif.gz_A Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1R,2S)-2-phenylcyclopropyl)urea	1.406E-05	1.000	117	28	274	284	8	228	253	265	0.870	0.874
LOKIASV2_0141_ESMFold_hypothetical_protein	2jkm-assembly1.cif.gz_A	2jkm-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	1.406E-05	1.000	117	28	278	284	9	257	260	282	0.884	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	5mrb-assembly1.cif.gz_A	5mrb-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Cpd-5	5.827E-05	1.000	117	29	271	284	12	241	264	267	0.856	0.871
LOKIASV2_0141_ESMFold_hypothetical_protein	5zwj-assembly1.cif.gz_A	5zwj-assembly1.cif.gz_A Crystal structure of EGFR 675-1022 T790M/C797S/V948R in complex with EAI045	3.823E-05	1.000	117	28	274	284	10	253	267	281	0.870	0.914
LOKIASV2_0141_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	2.174E-04	1.000	117	26	284	284	4	254	268	290	0.912	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	3cc6-assembly1.cif.gz_A	3cc6-assembly1.cif.gz_A Crystal structure of kinase domain of protein tyrosine kinase 2 beta (PTK2B)	2.509E-05	1.000	117	28	280	284	10	265	269	287	0.891	0.952
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly2.cif.gz_A	7jxh-assembly2.cif.gz_A HER2 in complex with JBJ-08-178-01	4.248E-05	1.000	117	34	273	284	13	265	272	284	0.845	0.930
LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	2.788E-05	1.000	117	28	271	284	19	246	272	267	0.859	0.838
LOKIASV2_0141_ESMFold_hypothetical_protein	8a2d-assembly1.cif.gz_A	8a2d-assembly1.cif.gz_A EGFR kinase domain (L858R/V948R) in complex with 2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-7-methyl-indazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-thiazol-2-yl-acetamide	7.582E-05	1.000	117	31	220	284	7	201	281	211	0.669	0.694
LOKIASV2_0141_ESMFold_hypothetical_protein	7a6i-assembly1.cif.gz_A	7a6i-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/V948R in Complex with LDC8201	5.244E-05	1.000	117	28	274	284	9	269	282	301	0.870	0.926
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	6.142E-05	1.000	117	28	274	284	13	278	282	304	0.870	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	1.426E-04	1.000	117	28	278	284	10	282	283	307	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	2.509E-05	1.000	117	34	271	284	8	261	286	287	0.838	0.888
LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A	5a46-assembly1.cif.gz_A FGFR1 in complex with dovitinib	4.478E-05	1.000	117	28	274	284	14	260	289	284	0.870	0.855
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB	7ozb-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.	4.248E-05	1.000	117	28	269	284	18	261	291	274	0.852	0.838
LOKIASV2_0141_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	4.543E-04	1.000	117	28	223	284	24	214	296	214	0.690	0.645
LOKIASV2_0141_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	4.720E-05	1.000	117	28	274	284	20	300	304	304	0.870	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	1.761E-04	1.000	117	35	213	284	2	183	317	204	0.630	0.574
LOKIASV2_0141_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	2.380E-05	1.000	116	36	271	284	11	240	261	264	0.831	0.881
LOKIASV2_0141_ESMFold_hypothetical_protein	4h1j-assembly1.cif.gz_A	4h1j-assembly1.cif.gz_A Crystal structure of PYK2 with the pyrazole 13a	4.030E-05	1.000	116	28	280	284	6	261	263	285	0.891	0.973
LOKIASV2_0141_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	2.938E-05	1.000	116	28	280	284	14	265	266	296	0.891	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly2.cif.gz_B	6bl8-assembly2.cif.gz_B Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	6.824E-05	1.000	116	32	275	284	6	261	268	291	0.859	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_B	2pz5-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	6.142E-05	1.000	116	29	279	284	7	279	280	301	0.884	0.975
LOKIASV2_0141_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B	5ew8-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693	3.823E-05	1.000	116	28	271	284	17	262	290	284	0.859	0.848
LOKIASV2_0141_ESMFold_hypothetical_protein	5nkg-assembly1.cif.gz_A	5nkg-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3d	1.670E-04	1.000	116	31	193	284	4	203	292	214	0.574	0.685
LOKIASV2_0141_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_B	8e1x-assembly1.cif.gz_B FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)	1.670E-04	1.000	116	26	220	284	12	228	293	231	0.687	0.741
LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	2.645E-05	1.000	116	28	277	284	13	292	293	312	0.880	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A	1t46-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	4.975E-05	1.000	116	28	273	284	24	294	297	297	0.866	0.912
LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	1.096E-04	1.000	116	28	279	284	19	304	305	312	0.887	0.938
LOKIASV2_0141_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	1.585E-04	1.000	116	28	271	284	7	281	343	305	0.859	0.802
LOKIASV2_0141_ESMFold_hypothetical_protein	4bhz-assembly1.cif.gz_A	4bhz-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	5.528E-05	1.000	115	36	271	284	10	229	251	256	0.831	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	4cv8-assembly1.cif.gz_A	4cv8-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	1.218E-04	1.000	115	29	271	284	10	233	255	264	0.856	0.878
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	1.585E-04	1.000	115	38	218	284	16	207	256	203	0.637	0.750
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E	5flf-assembly5.cif.gz_E DISEASE LINKED MUTATION IN FGFR	1.096E-04	1.000	115	29	239	284	6	254	258	258	0.743	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A	5uq0-assembly1.cif.gz_A FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide	6.142E-05	1.000	115	28	269	284	14	235	266	266	0.852	0.835
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	4.975E-05	1.000	115	45	282	284	20	261	267	275	0.838	0.906
LOKIASV2_0141_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	2.938E-05	1.000	115	28	273	284	9	272	273	299	0.866	0.967
LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B	4ymj-assembly2.cif.gz_B (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	5.827E-05	1.000	115	34	274	284	10	248	276	273	0.849	0.866
LOKIASV2_0141_ESMFold_hypothetical_protein	4rmz-assembly1.cif.gz_A	4rmz-assembly1.cif.gz_A Crystal Structure of IRAK-4	6.142E-05	1.000	115	12	274	284	10	286	287	338	0.926	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A	5lwm-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Compound 4 (FM381)	8.424E-05	1.000	115	34	271	284	7	265	290	290	0.838	0.893
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	9.359E-05	1.000	115	28	277	284	23	294	295	307	0.880	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	1.040E-04	1.000	115	28	219	284	5	215	297	237	0.676	0.710
LOKIASV2_0141_ESMFold_hypothetical_protein	2iwi-assembly1.cif.gz_A	2iwi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1	5.399E-03	1.000	114	31	181	284	3	146	244	159	0.532	0.590
LOKIASV2_0141_ESMFold_hypothetical_protein	2og8-assembly1.cif.gz_A	2og8-assembly1.cif.gz_A crystal structure of aminoquinazoline 36 bound to Lck	6.142E-05	1.000	114	28	271	284	8	224	246	266	0.859	0.882
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C	6yvs-assembly3.cif.gz_C FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	2.142E-05	1.000	114	28	280	284	8	253	254	284	0.891	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly2.cif.gz_B	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	7.193E-05	1.000	114	32	282	284	5	249	254	287	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A	4h1m-assembly1.cif.gz_A Crystal structure of PYK2 with the indole 10c	5.827E-05	1.000	114	28	280	284	5	254	256	277	0.891	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	3dbq-assembly1.cif.gz_A	3dbq-assembly1.cif.gz_A Crystal structure of TTK kinase domain	5.528E-05	1.000	114	29	269	284	11	232	259	256	0.849	0.857
LOKIASV2_0141_ESMFold_hypothetical_protein	2fb8-assembly2.cif.gz_B	2fb8-assembly2.cif.gz_B Structure of the B-Raf kinase domain bound to SB-590885	2.062E-04	1.000	114	28	220	284	8	212	259	225	0.680	0.792
LOKIASV2_0141_ESMFold_hypothetical_protein	4d58-assembly2.cif.gz_B	4d58-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	3.441E-05	1.000	114	28	278	284	8	258	261	280	0.884	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	5wnm-assembly1.cif.gz_A	5wnm-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein 4 (Ripk4) D143N bound to tozasertib (VX-680)	2.981E-04	1.000	114	31	274	284	13	260	263	288	0.859	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly9.cif.gz_I	3zfx-assembly9.cif.gz_I Crystal structure of EphB1	9.359E-05	1.000	114	28	282	284	8	259	263	294	0.898	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A	4ymj-assembly1.cif.gz_A (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	1.218E-04	1.000	114	28	274	284	11	246	271	274	0.870	0.871
LOKIASV2_0141_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A	4twn-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with Birb796	5.528E-05	1.000	114	31	282	284	9	265	276	300	0.887	0.931
LOKIASV2_0141_ESMFold_hypothetical_protein	5ntt-assembly1.cif.gz_A	5ntt-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715	8.424E-05	1.000	114	29	271	284	15	252	277	272	0.856	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.155E-04	1.000	114	35	271	284	2	255	278	283	0.835	0.914
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A	4tyj-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	4.975E-05	1.000	114	28	280	284	16	277	278	296	0.891	0.942
LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly1.cif.gz_A	3qqu-assembly1.cif.gz_A Cocrystal structure of unphosphorylated igf with pyrimidine 8	4.248E-05	1.000	114	32	234	284	5	223	285	233	0.715	0.768
LOKIASV2_0141_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A	4uxq-assembly1.cif.gz_A FGFR4 in complex with Ponatinib	2.509E-05	1.000	114	28	277	284	15	285	286	297	0.880	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	5t1t-assembly3.cif.gz_C	5t1t-assembly3.cif.gz_C Irak4 kinase - compound 1 co-structure	4.248E-05	1.000	114	48	274	284	35	286	289	294	0.799	0.872
LOKIASV2_0141_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	4.248E-05	1.000	114	28	274	284	20	260	289	277	0.870	0.834
LOKIASV2_0141_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A	3b8q-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	7.193E-05	1.000	114	28	283	284	16	286	292	305	0.901	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C	8pqg-assembly2.cif.gz_C c-KIT T670I mutated kinase domain in complex with avapritinib	7.992E-05	1.000	114	28	277	284	24	299	300	311	0.880	0.920
LOKIASV2_0141_ESMFold_hypothetical_protein	2zm3-assembly1.cif.gz_A	2zm3-assembly1.cif.gz_A Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor	7.992E-05	1.000	114	34	238	284	18	286	303	278	0.722	0.888
LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	5.244E-05	1.000	114	28	274	284	17	276	305	293	0.870	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	5.827E-05	1.000	113	28	273	284	7	263	265	283	0.866	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	8bof-assembly1.cif.gz_A	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	3.492E-04	1.000	113	32	214	284	5	198	266	214	0.644	0.729
LOKIASV2_0141_ESMFold_hypothetical_protein	4f1t-assembly1.cif.gz_A	4f1t-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum bound to the ROCK Inhibitor H1152	2.205E-03	1.000	113	36	180	284	10	161	269	165	0.511	0.565
LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A	5vam-assembly1.cif.gz_A BRAF in Complex with RAF709	5.244E-05	1.000	113	28	277	284	8	268	269	289	0.880	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx0-assembly1.cif.gz_A	2vx0-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	9.865E-05	1.000	113	28	282	284	7	268	273	299	0.898	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B	5am6-assembly2.cif.gz_B Native FGFR1 with an inhibitor	9.865E-05	1.000	113	28	269	284	20	252	280	270	0.852	0.832
LOKIASV2_0141_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA	8atb-assembly1.cif.gz_AAA Discovery of IRAK4 Inhibitor 16	1.040E-04	1.000	113	38	275	284	24	279	280	287	0.838	0.914
LOKIASV2_0141_ESMFold_hypothetical_protein	6kzc-assembly1.cif.gz_A	6kzc-assembly1.cif.gz_A crystal structure of TRKc in complex with 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methyl-N-(3-((4- methylpiperazin-1-yl)methyl)-5- (trifluoromethyl)phenyl)benzamide	3.680E-04	1.000	113	28	228	284	10	213	281	224	0.708	0.726
LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A	5o4a-assembly1.cif.gz_A Human FGF in complex with a covalent inhibitor	2.828E-04	1.000	113	28	220	284	14	223	290	228	0.680	0.724
LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B	7v29-assembly1.cif.gz_B Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	4.248E-05	1.000	113	28	277	284	13	289	290	309	0.880	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	3lvp-assembly3.cif.gz_C	3lvp-assembly3.cif.gz_C Crystal structure of bisphosphorylated IGF1-R Kinase domain (2P) in complex with a bis-azaindole inhibitor	1.956E-04	1.000	113	29	238	284	6	275	293	280	0.739	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	5.609E-04	1.000	113	35	223	284	4	194	294	217	0.665	0.650
LOKIASV2_0141_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	8.879E-05	1.000	113	17	272	284	2	273	295	309	0.901	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A	8pqd-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 10	7.193E-05	1.000	113	28	277	284	23	296	297	308	0.880	0.923
LOKIASV2_0141_ESMFold_hypothetical_protein	7f3m-assembly1.cif.gz_A	7f3m-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with PRN1371	4.030E-05	1.000	113	28	277	284	14	294	298	316	0.880	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C	6v6a-assembly2.cif.gz_C Inhibitory scaffolding of the ancient MAPK, ERK7	1.040E-04	1.000	113	34	229	284	7	268	299	275	0.690	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	4.478E-05	1.000	113	28	277	284	14	297	300	318	0.880	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	9.359E-05	1.000	112	29	271	284	11	234	258	259	0.856	0.868
LOKIASV2_0141_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	2.174E-04	1.000	112	28	270	284	7	263	266	294	0.856	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	6tfu-assembly1.cif.gz_A	6tfu-assembly1.cif.gz_A Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14d	5.827E-05	1.000	112	28	283	284	12	258	267	295	0.901	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	6ziw-assembly1.cif.gz_I	6ziw-assembly1.cif.gz_I The IRAK3 Pseudokinase Domain Bound To ATPgammaS	1.353E-04	1.000	112	37	277	284	17	265	267	277	0.849	0.933
LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly1.cif.gz_A	6tg1-assembly1.cif.gz_A Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b	6.824E-05	1.000	112	31	272	284	9	257	268	279	0.852	0.929
LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B	6yi8-assembly2.cif.gz_B HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	7.992E-05	1.000	112	28	278	284	16	268	270	293	0.884	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B	5nud-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	9.359E-05	1.000	112	28	277	284	19	270	271	292	0.880	0.930
LOKIASV2_0141_ESMFold_hypothetical_protein	5gnk-assembly1.cif.gz_A	5gnk-assembly1.cif.gz_A Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34	3.627E-05	1.000	112	31	274	284	11	263	277	284	0.859	0.913
LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	6.142E-05	1.000	112	28	277	284	14	273	277	290	0.880	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB	7ozd-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	6.824E-05	1.000	112	28	274	284	18	279	285	296	0.870	0.919
LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly3.cif.gz_C	6p68-assembly3.cif.gz_C Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	6.474E-05	1.000	112	28	284	284	8	268	286	295	0.905	0.913
LOKIASV2_0141_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B	4nka-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	4.720E-05	1.000	112	28	271	284	20	259	287	279	0.859	0.836
LOKIASV2_0141_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	2.546E-04	1.000	112	28	272	284	16	269	289	298	0.863	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A	8pqg-assembly1.cif.gz_A c-KIT T670I mutated kinase domain in complex with avapritinib	1.155E-04	1.000	112	28	273	284	23	287	292	296	0.866	0.908
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A	8pqi-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9	1.155E-04	1.000	112	28	283	284	26	293	299	300	0.901	0.896
LOKIASV2_0141_ESMFold_hypothetical_protein	6wa2-assembly2.cif.gz_C	6wa2-assembly2.cif.gz_C Crystal structure of EGFR(T790M/V948R) in complex with LN3753	1.096E-04	1.000	112	31	220	284	7	197	300	212	0.669	0.637
LOKIASV2_0141_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	9.359E-05	1.000	111	28	273	284	9	249	251	277	0.866	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap3-assembly1.cif.gz_A	5ap3-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	7.582E-05	1.000	111	36	271	284	10	232	254	256	0.831	0.878
LOKIASV2_0141_ESMFold_hypothetical_protein	5na0-assembly1.cif.gz_A	5na0-assembly1.cif.gz_A TTK kinase domain in complex with a PEG-linked pyrimido-indolizine	3.879E-04	1.000	111	29	220	284	10	187	254	203	0.676	0.701
LOKIASV2_0141_ESMFold_hypothetical_protein	6yxv-assembly2.cif.gz_B	6yxv-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-{3-[(2-phenylamino-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl]-pyridin-2-yl}-methanesulfonamide	4.720E-05	1.000	111	26	277	284	5	256	260	285	0.887	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	1.218E-04	1.000	111	28	274	284	7	244	261	282	0.870	0.912
LOKIASV2_0141_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A	7aw4-assembly1.cif.gz_A MerTK kinase domain with type 3 inhibitor from a DNA-encoded library	9.359E-05	1.000	111	28	277	284	11	262	264	296	0.880	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A	1vr2-assembly1.cif.gz_A HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN	9.865E-05	1.000	111	28	274	284	14	274	275	290	0.870	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	5.912E-04	1.000	111	28	222	284	6	201	276	220	0.687	0.710
LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A	8stg-assembly1.cif.gz_A Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	6.142E-05	1.000	111	26	269	284	18	250	277	275	0.859	0.841
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	8.424E-05	1.000	111	28	271	284	19	274	301	295	0.859	0.850
LOKIASV2_0141_ESMFold_hypothetical_protein	5cav-assembly1.cif.gz_A	5cav-assembly1.cif.gz_A EGFR kinase domain with compound 41a	4.975E-05	1.000	111	34	274	284	14	275	306	295	0.849	0.856
LOKIASV2_0141_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	1.055E-03	1.000	111	28	175	284	6	149	317	158	0.521	0.454
LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_B	2rio-assembly1.cif.gz_B Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	4.789E-04	1.000	111	28	223	284	8	201	395	221	0.690	0.491
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	6.824E-05	1.000	110	36	271	284	11	230	252	261	0.831	0.873
LOKIASV2_0141_ESMFold_hypothetical_protein	7kpl-assembly1.cif.gz_A	7kpl-assembly1.cif.gz_A Crystal structure of hEphB1 in apo form	1.761E-04	1.000	110	28	282	284	8	255	256	292	0.898	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	4k8a-assembly2.cif.gz_B	4k8a-assembly2.cif.gz_B Fragment-based discovery of Focal Adhesion Kinase Inhibitors	3.627E-05	1.000	110	28	277	284	8	256	258	286	0.880	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	6.474E-05	1.000	110	35	234	284	1	211	259	230	0.704	0.815
LOKIASV2_0141_ESMFold_hypothetical_protein	3lzb-assembly2.cif.gz_B	3lzb-assembly2.cif.gz_B EGFR kinase domain complexed with an imidazo[2,1-b]thiazole inhibitor	1.585E-04	1.000	110	28	283	284	9	255	265	285	0.901	0.932
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	1.096E-04	1.000	110	28	274	284	15	240	267	267	0.870	0.846
LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly1.cif.gz_A	5nud-assembly1.cif.gz_A FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	1.218E-04	1.000	110	28	280	284	14	266	267	293	0.891	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	6rbd-assembly1.cif.gz_l	6rbd-assembly1.cif.gz_l State 1 of yeast Tsr1-TAP Rps20-Deltaloop pre-40S particles	5.048E-04	1.000	110	15	238	284	68	254	271	239	0.789	0.690
LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	7.582E-05	1.000	110	28	271	284	18	254	280	277	0.859	0.846
LOKIASV2_0141_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	1.096E-04	1.000	110	28	273	284	17	286	289	307	0.866	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	9.359E-05	1.000	110	28	269	284	18	264	295	278	0.852	0.837
LOKIASV2_0141_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A	7yc3-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with 10t	7.193E-05	1.000	110	28	277	284	14	297	300	314	0.880	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	5x2c-assembly2.cif.gz_B	5x2c-assembly2.cif.gz_B Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(5)	8.879E-05	1.000	110	28	278	284	11	257	303	289	0.884	0.815
LOKIASV2_0141_ESMFold_hypothetical_protein	5cnn-assembly2.cif.gz_B	5cnn-assembly2.cif.gz_B Crystal structure of the EGFR kinase domain mutant I682Q	9.865E-05	1.000	110	28	278	284	12	258	304	289	0.884	0.812
LOKIASV2_0141_ESMFold_hypothetical_protein	5ehy-assembly1.cif.gz_A	5ehy-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	1.155E-04	1.000	109	36	271	284	11	233	255	258	0.831	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	8.879E-05	1.000	109	36	271	284	11	234	256	259	0.831	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	1.284E-04	1.000	109	29	271	284	10	234	256	264	0.856	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	3sxr-assembly3.cif.gz_A	3sxr-assembly3.cif.gz_A Crystal structure of BMX non-receptor tyrosine kinase complex with dasatinib	7.193E-05	1.000	109	31	274	284	5	258	260	291	0.859	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	3h9f-assembly1.cif.gz_A	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	1.218E-04	1.000	109	36	271	284	11	241	263	262	0.831	0.878
LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	2.415E-04	1.000	109	14	226	284	4	188	263	231	0.750	0.703
LOKIASV2_0141_ESMFold_hypothetical_protein	7pi4-assembly1.cif.gz_DDD	7pi4-assembly1.cif.gz_DDD FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB	4.720E-05	1.000	109	28	277	284	7	259	264	285	0.880	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	5jkg-assembly1.cif.gz_A	5jkg-assembly1.cif.gz_A The crystal structure of FGFR4 kinase domain in complex with LY2874455	4.543E-04	1.000	109	28	220	284	14	202	266	214	0.680	0.711
LOKIASV2_0141_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	5.321E-04	1.000	109	9	216	284	1	229	287	250	0.732	0.798
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	6.142E-05	1.000	109	28	277	284	23	291	293	306	0.880	0.918
LOKIASV2_0141_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A	2v7o-assembly1.cif.gz_A Crystal structure of human calcium-calmodulin-dependent protein kinase II gamma	2.062E-04	1.000	109	28	256	284	18	303	306	301	0.806	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly1.cif.gz_A	7wcl-assembly1.cif.gz_A Crystal structure of FGFR1 kinase domain with Pemigatinib	3.492E-04	1.000	109	28	239	284	19	299	306	289	0.746	0.918
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly2.cif.gz_B	6yvs-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	4.030E-05	1.000	108	28	277	284	7	250	254	281	0.880	0.961
LOKIASV2_0141_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	1.353E-04	1.000	108	39	271	284	18	233	255	253	0.820	0.847
LOKIASV2_0141_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	1.284E-04	1.000	108	36	271	284	10	235	258	262	0.831	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	9.359E-05	1.000	108	36	271	284	11	238	259	261	0.831	0.880
LOKIASV2_0141_ESMFold_hypothetical_protein	3uqf-assembly1.cif.gz_A	3uqf-assembly1.cif.gz_A c-SRC kinase domain in complex with BKI RM-1-89	1.218E-04	1.000	108	28	284	284	9	256	260	288	0.905	0.954
LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly2.cif.gz_B	5vam-assembly2.cif.gz_B BRAF in Complex with RAF709	1.856E-04	1.000	108	28	277	284	8	259	260	285	0.880	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	2.291E-04	1.000	108	29	239	284	8	256	262	263	0.743	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	5wnj-assembly1.cif.gz_A	5wnj-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with lestaurtinib	5.912E-04	1.000	108	31	274	284	13	261	264	288	0.859	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	7lqd-assembly1.cif.gz_A	7lqd-assembly1.cif.gz_A Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor	1.761E-04	1.000	108	37	271	284	15	246	269	267	0.827	0.862
LOKIASV2_0141_ESMFold_hypothetical_protein	5xff-assembly1.cif.gz_A	5xff-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)	1.856E-04	1.000	108	28	277	284	14	268	269	299	0.880	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	5nka-assembly1.cif.gz_A	5nka-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g	4.478E-05	1.000	108	31	282	284	4	258	271	298	0.887	0.941
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	5.528E-05	1.000	108	36	271	284	11	249	272	275	0.831	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	5.244E-05	1.000	108	34	274	284	8	252	274	277	0.849	0.894
LOKIASV2_0141_ESMFold_hypothetical_protein	5fdx-assembly1.cif.gz_A	5fdx-assembly1.cif.gz_A Structure of DDR1 receptor tyrosine kinase in complex with D2164 inhibitor at 2.65 Angstroms resolution.	7.193E-05	1.000	108	28	273	284	6	278	280	302	0.866	0.975
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwi-assembly2.cif.gz_B	4rwi-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo	9.359E-05	1.000	108	28	274	284	17	274	280	288	0.870	0.921
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B	8pqe-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 11	2.174E-04	1.000	108	28	273	284	23	279	283	291	0.866	0.908
LOKIASV2_0141_ESMFold_hypothetical_protein	6sdc-assembly1.cif.gz_A	6sdc-assembly1.cif.gz_A Crystal structure of D1228V cMET bound by foretinib	5.609E-04	1.000	108	1	220	284	1	220	286	244	0.775	0.769
LOKIASV2_0141_ESMFold_hypothetical_protein	7q52-assembly1.cif.gz_AAA	7q52-assembly1.cif.gz_AAA Crystal structure of S/T protein kinase PknG from Mycobacterium tuberculosis in complex with inhibitor L2W	5.827E-05	1.000	108	28	275	284	58	308	312	282	0.873	0.804
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	3.312E-04	1.000	107	29	271	284	11	236	258	263	0.856	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	6gcr-assembly1.cif.gz_A	6gcr-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	5.827E-05	1.000	107	28	278	284	9	257	258	281	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	1.426E-04	1.000	107	36	271	284	10	237	260	265	0.831	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	5ia0-assembly1.cif.gz_A	5ia0-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237)	9.359E-05	1.000	107	32	282	284	6	254	263	293	0.884	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C	6vg3-assembly3.cif.gz_C Structure of unliganded, inactive PTK7 kinase domain	1.761E-04	1.000	107	28	272	284	7	264	265	288	0.863	0.974
LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly2.cif.gz_B	6tg1-assembly2.cif.gz_B Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b	9.359E-05	1.000	107	31	273	284	10	261	271	280	0.856	0.930
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyk-assembly1.cif.gz_AAA	8pyk-assembly1.cif.gz_AAA Human IGF1R with inhibitor 47	2.415E-04	1.000	107	28	238	284	13	272	274	272	0.743	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B	8stg-assembly2.cif.gz_B Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	1.426E-04	1.000	107	34	278	284	8	273	274	279	0.863	0.971
LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly1.cif.gz_A	7atu-assembly1.cif.gz_A The LIMK1 Kinase Domain Bound To LIJTF500025	6.232E-04	1.000	107	37	228	284	8	192	276	209	0.676	0.670
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	1.040E-04	1.000	107	28	274	284	19	276	282	287	0.870	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A	7mfc-assembly1.cif.gz_A Crystal structure of CSF1R in complex with vimseltinib	9.865E-05	1.000	107	26	273	284	13	286	287	300	0.873	0.955
LOKIASV2_0141_ESMFold_hypothetical_protein	4v05-assembly1.cif.gz_A	4v05-assembly1.cif.gz_A FGFR1 in complex with AZD4547.	1.040E-04	1.000	107	28	274	284	14	258	287	281	0.870	0.854
LOKIASV2_0141_ESMFold_hypothetical_protein	6itj-assembly2.cif.gz_B	6itj-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain in complex with compound 3	1.353E-04	1.000	107	28	271	284	19	269	293	288	0.859	0.857
LOKIASV2_0141_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A	6xva-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing an acrylamide	8.879E-05	1.000	107	28	273	284	20	289	294	299	0.866	0.918
LOKIASV2_0141_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A	8pq9-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib	2.291E-04	1.000	107	28	273	284	23	295	296	300	0.866	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	2.415E-04	1.000	106	28	274	284	8	244	247	277	0.870	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	3gfw-assembly1.cif.gz_A	3gfw-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin ligand	2.415E-04	1.000	106	38	272	284	16	228	253	248	0.827	0.842
LOKIASV2_0141_ESMFold_hypothetical_protein	5eho-assembly1.cif.gz_A	5eho-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	9.865E-05	1.000	106	36	271	284	10	236	258	263	0.831	0.880
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzp-assembly1.cif.gz_A	3fzp-assembly1.cif.gz_A Crystal structure of PYK2 complexed with ATPgS	9.865E-05	1.000	106	28	280	284	6	255	259	279	0.891	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	2ijm-assembly1.cif.gz_A	2ijm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain with 2 molecules in the Asymmetric Unit Complexed with ADP and ATP	4.030E-05	1.000	106	29	283	284	2	260	260	295	0.898	0.996
LOKIASV2_0141_ESMFold_hypothetical_protein	2yn8-assembly2.cif.gz_B	2yn8-assembly2.cif.gz_B ephB4 kinase domain inhibitor complex	1.096E-04	1.000	106	28	282	284	9	255	260	293	0.898	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzo-assembly1.cif.gz_A	3fzo-assembly1.cif.gz_A Crystal Structure of PYK2-Apo, Proline-rich Tyrosine Kinase	2.174E-04	1.000	106	28	280	284	5	259	262	285	0.891	0.973
LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_C	7xbr-assembly2.cif.gz_C Crystal structure of phosphorylated AtMKK5	2.291E-04	1.000	106	34	220	284	5	198	266	215	0.658	0.729
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnm-assembly1.cif.gz_A	6fnm-assembly1.cif.gz_A Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with Dasatinib	1.761E-04	1.000	106	28	282	284	7	264	270	291	0.898	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	2qkr-assembly1.cif.gz_A	2qkr-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound	2.092E-03	1.000	106	29	191	284	2	155	273	181	0.574	0.564
LOKIASV2_0141_ESMFold_hypothetical_protein	6pmc-assembly1.cif.gz_A	6pmc-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 1a	9.865E-05	1.000	106	28	272	284	10	276	289	291	0.863	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	4r1v-assembly1.cif.gz_A	4r1v-assembly1.cif.gz_A Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors	1.155E-04	1.000	106	28	275	284	21	285	289	305	0.873	0.917
LOKIASV2_0141_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	1.353E-04	1.000	106	28	271	284	19	266	291	286	0.859	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	5nkf-assembly1.cif.gz_A	5nkf-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3b	1.426E-04	1.000	106	31	284	284	4	279	291	303	0.894	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	6jpe-assembly1.cif.gz_A	6jpe-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1	7.582E-05	1.000	106	28	277	284	15	296	298	316	0.880	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	6ty4-assembly1.cif.gz_B	6ty4-assembly1.cif.gz_B FAK structure with AMP-PNP from single particle analysis of 2D crystals	1.670E-04	1.000	106	26	278	284	354	618	621	294	0.891	0.427
LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly3.cif.gz_C	7atu-assembly3.cif.gz_C The LIMK1 Kinase Domain Bound To LIJTF500025	1.373E-03	1.000	105	67	228	284	7	162	244	172	0.570	0.639
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	2.174E-04	1.000	105	36	271	284	10	231	253	252	0.831	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly1.cif.gz_A	4d4v-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain	1.218E-04	1.000	105	28	278	284	7	253	256	283	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	8.879E-05	1.000	105	36	271	284	10	236	258	263	0.831	0.880
LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly1.cif.gz_A	4o6l-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	1.426E-04	1.000	105	36	271	284	11	239	260	258	0.831	0.881
LOKIASV2_0141_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	1.218E-04	1.000	105	36	271	284	11	242	265	264	0.831	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A	3zzw-assembly1.cif.gz_A Crystal structure of the kinase domain of ROR2	1.040E-04	1.000	105	32	273	284	4	267	269	289	0.852	0.981
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	7.298E-04	1.000	105	28	234	284	6	213	277	226	0.729	0.751
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B	2hak-assembly2.cif.gz_B Catalytic and ubiqutin-associated domains of MARK1/PAR-1	3.936E-03	1.000	105	28	191	284	7	164	279	174	0.577	0.566
LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly2.cif.gz_B	5zv2-assembly2.cif.gz_B FGFR-1 in complex with ligand lenvatinib	1.353E-04	1.000	105	28	274	284	18	275	282	284	0.870	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	7v3r-assembly1.cif.gz_A	7v3r-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	7.298E-04	1.000	105	28	220	284	23	220	285	217	0.680	0.695
LOKIASV2_0141_ESMFold_hypothetical_protein	5am7-assembly2.cif.gz_B	5am7-assembly2.cif.gz_B FGFR1 mutant with an inhibitor	1.585E-04	1.000	105	28	269	284	20	259	287	280	0.852	0.836
LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B	3qqu-assembly2.cif.gz_B Cocrystal structure of unphosphorylated igf with pyrimidine 8	1.218E-04	1.000	105	32	269	284	8	248	288	267	0.838	0.837
LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B	5o4a-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	1.096E-04	1.000	105	28	274	284	18	285	291	295	0.870	0.921
LOKIASV2_0141_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	3.680E-04	1.000	105	28	274	284	5	244	304	281	0.870	0.789
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly2.cif.gz_B	2j0k-assembly2.cif.gz_B Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	8.424E-05	1.000	105	28	278	284	361	609	612	284	0.884	0.407
LOKIASV2_0141_ESMFold_hypothetical_protein	7kxw-assembly1.cif.gz_A	7kxw-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	2.546E-04	1.000	104	14	271	284	4	227	247	293	0.908	0.907
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi2-assembly1.cif.gz_A	4bi2-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.062E-04	1.000	104	29	271	284	10	231	253	261	0.856	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	2jko-assembly1.cif.gz_A	2jko-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	6.824E-05	1.000	104	28	278	284	7	253	256	282	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	9.359E-05	1.000	104	36	271	284	10	235	257	266	0.831	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	6yr9-assembly2.cif.gz_B	6yr9-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-(2-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-phenyl)-methanesulfonamide	7.193E-05	1.000	104	26	278	284	6	257	258	292	0.891	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	7chm-assembly1.cif.gz_A	7chm-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 8	1.956E-04	1.000	104	40	272	284	18	235	260	258	0.820	0.838
LOKIASV2_0141_ESMFold_hypothetical_protein	4nwm-assembly2.cif.gz_B	4nwm-assembly2.cif.gz_B Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide	7.582E-05	1.000	104	31	274	284	3	259	262	284	0.859	0.981
LOKIASV2_0141_ESMFold_hypothetical_protein	3h3c-assembly1.cif.gz_A	3h3c-assembly1.cif.gz_A Crystal structure of PYK2 in complex with Sulfoximine-substituted trifluoromethylpyrimidine analog	8.424E-05	1.000	104	28	277	284	9	256	263	279	0.880	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	1.670E-04	1.000	104	40	271	284	19	240	265	256	0.817	0.838
LOKIASV2_0141_ESMFold_hypothetical_protein	4k9y-assembly1.cif.gz_A	4k9y-assembly1.cif.gz_A FOCAL ADHESION KINASE Catalytic domain in complex with 1-[4-(6-Amino-purin-9-yl)-phenyl]-3-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-urea	4.975E-05	1.000	104	28	278	284	7	269	271	295	0.884	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvh-assembly1.cif.gz_A	6nvh-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	1.503E-04	1.000	104	28	277	284	14	270	271	290	0.880	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly5.cif.gz_E	6fer-assembly5.cif.gz_E Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	4.089E-04	1.000	104	32	219	284	7	205	273	226	0.662	0.729
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6p-assembly1.cif.gz_A	5l6p-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)	1.353E-04	1.000	104	35	282	284	1	270	274	303	0.873	0.985
LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly1.cif.gz_A	6c19-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN36985	5.912E-04	1.000	104	28	239	284	14	268	276	271	0.746	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	6.824E-05	1.000	104	48	284	284	18	283	283	299	0.835	0.940
LOKIASV2_0141_ESMFold_hypothetical_protein	4zy5-assembly1.cif.gz_A	4zy5-assembly1.cif.gz_A Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	3.492E-04	1.000	104	37	272	284	23	263	283	281	0.831	0.852
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyi-assembly7.cif.gz_GGG	8pyi-assembly7.cif.gz_GGG Human IGF1R with inhibitor 6	2.062E-04	1.000	104	34	269	284	11	245	284	263	0.831	0.827
LOKIASV2_0141_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	3.879E-04	1.000	104	36	270	284	3	213	290	264	0.827	0.728
LOKIASV2_0141_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A	6nsp-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 9	1.585E-04	1.000	104	28	272	284	10	280	293	299	0.863	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	3cth-assembly1.cif.gz_A	3cth-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor	9.359E-05	1.000	104	32	277	284	21	278	295	288	0.866	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	5wr7-assembly1.cif.gz_A	5wr7-assembly1.cif.gz_A Crystal structure of Trk-A complexed with a selective inhibitor CH7057288	2.415E-04	1.000	104	28	274	284	21	294	302	309	0.870	0.907
LOKIASV2_0141_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A	6il3-assembly1.cif.gz_A Crystal structure of the FLT3 kinase bound to a small molecule inhibitor	3.680E-04	1.000	104	28	271	284	41	289	310	280	0.859	0.803
LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly2.cif.gz_B	7kx8-assembly2.cif.gz_B Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	9.496E-04	1.000	103	28	226	284	10	189	251	212	0.701	0.717
LOKIASV2_0141_ESMFold_hypothetical_protein	6gcw-assembly1.cif.gz_A	6gcw-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	9.359E-05	1.000	103	28	278	284	8	252	254	283	0.884	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	2.683E-04	1.000	103	37	271	284	15	235	256	257	0.827	0.863
LOKIASV2_0141_ESMFold_hypothetical_protein	3hmp-assembly1.cif.gz_A	3hmp-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4	2.062E-04	1.000	103	38	271	284	15	236	258	256	0.824	0.860
LOKIASV2_0141_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A	6vzk-assembly1.cif.gz_A Crystal structure of human CaMKII-alpha (CAMK2A)kinase domain	1.303E-03	1.000	103	28	222	284	6	255	258	272	0.687	0.969
LOKIASV2_0141_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	2.546E-04	1.000	103	29	271	284	13	237	259	263	0.856	0.869
LOKIASV2_0141_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	2.546E-04	1.000	103	38	269	284	15	235	260	255	0.817	0.850
LOKIASV2_0141_ESMFold_hypothetical_protein	2etm-assembly1.cif.gz_A	2etm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain Complexed with 7H-Pyrrolo [2,3-d] pyrimidine Derivative	4.975E-05	1.000	103	32	274	284	4	259	262	275	0.856	0.977
LOKIASV2_0141_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A	5igu-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II	7.298E-04	1.000	103	48	272	284	2	263	264	302	0.792	0.992
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6o-assembly1.cif.gz_A	5l6o-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)	2.828E-04	1.000	103	29	282	284	2	263	267	292	0.894	0.981
LOKIASV2_0141_ESMFold_hypothetical_protein	6n0p-assembly1.cif.gz_A	6n0p-assembly1.cif.gz_A BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)	3.142E-04	1.000	103	28	277	284	8	267	268	291	0.880	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvj-assembly1.cif.gz_A	6nvj-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide	2.828E-04	1.000	103	28	277	284	14	268	270	290	0.880	0.944
LOKIASV2_0141_ESMFold_hypothetical_protein	8eme-assembly1.cif.gz_B	8eme-assembly1.cif.gz_B EGFR(T790M/V948R) in complex with ZNL-0056	7.992E-05	1.000	103	31	274	284	6	251	282	283	0.859	0.872
LOKIASV2_0141_ESMFold_hypothetical_protein	4eev-assembly1.cif.gz_A	4eev-assembly1.cif.gz_A Crystal structure of c-Met in complex with LY2801653	1.112E-03	1.000	103	28	220	284	31	217	283	211	0.680	0.661
LOKIASV2_0141_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	5.048E-04	1.000	103	23	274	284	2	245	284	285	0.887	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	4xs2-assembly3.cif.gz_C	4xs2-assembly3.cif.gz_C Irak4-inhibitor co-structure	4.310E-04	1.000	103	48	274	284	35	281	284	290	0.799	0.870
LOKIASV2_0141_ESMFold_hypothetical_protein	1jqh-assembly2.cif.gz_B	1jqh-assembly2.cif.gz_B IGF-1 receptor kinase domain	3.142E-04	1.000	103	32	234	284	12	224	287	229	0.715	0.742
LOKIASV2_0141_ESMFold_hypothetical_protein	5sav-assembly1.cif.gz_A	5sav-assembly1.cif.gz_A DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 1.760A, P212121, Rfree=23.5%	4.310E-04	1.000	103	28	219	284	8	221	291	234	0.676	0.735
LOKIASV2_0141_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	3.680E-04	1.000	103	24	273	284	2	287	293	310	0.880	0.976
LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	2.828E-04	1.000	103	28	271	284	20	269	297	280	0.859	0.842
LOKIASV2_0141_ESMFold_hypothetical_protein	6duk-assembly3.cif.gz_F	6duk-assembly3.cif.gz_F EGFR with an allosteric inhibitor	1.426E-04	1.000	103	28	283	284	11	262	298	292	0.901	0.846
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	1.670E-04	1.000	103	28	274	284	19	270	299	292	0.870	0.843
LOKIASV2_0141_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	4.543E-04	1.000	103	28	218	284	6	202	300	213	0.673	0.657
LOKIASV2_0141_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	2.415E-04	1.000	103	28	278	284	7	281	306	302	0.884	0.899
LOKIASV2_0141_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	2.415E-04	1.000	102	29	271	284	13	228	249	255	0.856	0.867
LOKIASV2_0141_ESMFold_hypothetical_protein	6uuo-assembly2.cif.gz_A	6uuo-assembly2.cif.gz_A Crystal structure of BRAF kinase domain bound to the PROTAC P4B	1.284E-04	1.000	102	32	274	284	4	228	254	279	0.856	0.886
LOKIASV2_0141_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	4.859E-03	1.000	102	42	181	284	1	146	256	155	0.493	0.570
LOKIASV2_0141_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	1.761E-04	1.000	102	36	271	284	10	235	257	263	0.831	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	3hmo-assembly1.cif.gz_A	3hmo-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine	2.291E-04	1.000	102	29	271	284	12	235	257	263	0.856	0.872
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	2.062E-04	1.000	102	37	271	284	1	240	262	269	0.827	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	1.761E-04	1.000	102	36	271	284	10	242	264	268	0.831	0.883
LOKIASV2_0141_ESMFold_hypothetical_protein	7m5z-assembly2.cif.gz_B	7m5z-assembly2.cif.gz_B Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	3.680E-04	1.000	102	28	277	284	13	262	264	293	0.880	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	6gvj-assembly1.cif.gz_A	6gvj-assembly1.cif.gz_A Human Mps1 kinase domain with ordered activation loop	2.546E-04	1.000	102	35	271	284	2	249	272	282	0.835	0.912
LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly1.cif.gz_A	7lg8-assembly1.cif.gz_A EGFR (T79M/V948R) in complex with naquotinib and an allosteric inhibitor	2.291E-04	1.000	102	28	274	284	10	255	280	280	0.870	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly1.cif.gz_A	5zv2-assembly1.cif.gz_A FGFR-1 in complex with ligand lenvatinib	3.142E-04	1.000	102	28	271	284	15	259	284	286	0.859	0.863
LOKIASV2_0141_ESMFold_hypothetical_protein	5eob-assembly1.cif.gz_A	5eob-assembly1.cif.gz_A Crystal structure of CMET in complex with novel inhibitor	3.312E-04	1.000	102	28	277	284	21	286	288	294	0.880	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	2.683E-04	1.000	102	28	273	284	3	286	290	308	0.866	0.979
LOKIASV2_0141_ESMFold_hypothetical_protein	3c4f-assembly2.cif.gz_B	3c4f-assembly2.cif.gz_B FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole	2.174E-04	1.000	102	28	271	284	14	262	290	287	0.859	0.859
LOKIASV2_0141_ESMFold_hypothetical_protein	5a4c-assembly1.cif.gz_A	5a4c-assembly1.cif.gz_A FGFR1 ligand complex	1.856E-04	1.000	102	29	274	284	8	265	294	290	0.866	0.878
LOKIASV2_0141_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	1.956E-04	1.000	102	28	277	284	14	297	300	318	0.880	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	1.001E-03	1.000	102	28	242	284	37	294	303	272	0.757	0.851
LOKIASV2_0141_ESMFold_hypothetical_protein	3ndm-assembly1.cif.gz_A	3ndm-assembly1.cif.gz_A Crystal structure of Rho-Associated Protein Kinase (ROCK1) with a potent isoquinolone derivative	8.109E-04	1.000	102	13	217	284	50	260	383	240	0.722	0.551
LOKIASV2_0141_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	4.089E-04	1.000	101	29	271	284	10	234	256	264	0.856	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	2zmd-assembly1.cif.gz_A	2zmd-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor	2.174E-04	1.000	101	36	271	284	10	236	259	263	0.831	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	2.546E-04	1.000	101	28	271	284	16	236	260	267	0.859	0.850
LOKIASV2_0141_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	1.670E-04	1.000	101	36	271	284	10	237	260	262	0.831	0.877
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap6-assembly1.cif.gz_A	5ap6-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	1.856E-04	1.000	101	36	271	284	10	240	262	267	0.831	0.882
LOKIASV2_0141_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B	3efl-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with motesanib	3.312E-04	1.000	101	28	274	284	13	261	263	289	0.870	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	5wni-assembly1.cif.gz_A	5wni-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with ATP	4.310E-04	1.000	101	38	274	284	17	261	263	275	0.835	0.932
LOKIASV2_0141_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	1.585E-04	1.000	101	36	271	284	11	242	266	260	0.831	0.872
LOKIASV2_0141_ESMFold_hypothetical_protein	8hmt-assembly2.cif.gz_B	8hmt-assembly2.cif.gz_B The complex of ACK1 with the inhibitor 2-142	4.789E-04	1.000	101	34	273	284	8	268	269	292	0.845	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	1.856E-04	1.000	101	29	271	284	13	252	273	282	0.856	0.879
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx1-assembly1.cif.gz_A	2vx1-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	2.291E-04	1.000	101	32	284	284	4	273	274	302	0.891	0.985
LOKIASV2_0141_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	1.172E-03	1.000	101	29	274	284	11	275	276	300	0.866	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	2ac3-assembly1.cif.gz_A	2ac3-assembly1.cif.gz_A Structure of human Mnk2 Kinase Domain	1.985E-03	1.000	101	29	217	284	14	230	277	231	0.665	0.783
LOKIASV2_0141_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A	6jol-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with imatinib by co-crystallization	3.142E-04	1.000	101	28	274	284	10	275	279	293	0.870	0.953
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly1.cif.gz_A	6c1o-assembly1.cif.gz_A FGFR1 kinase domain complexed with FIIN-1	2.683E-04	1.000	101	28	274	284	14	272	280	293	0.870	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	5.609E-04	1.000	101	28	273	284	13	286	289	314	0.866	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A	6xvb-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	3.492E-04	1.000	101	28	273	284	20	292	297	300	0.866	0.919
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnb-assembly1.cif.gz_A	6tnb-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41	2.415E-04	1.000	100	35	271	284	8	230	252	252	0.835	0.885
LOKIASV2_0141_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	4.089E-04	1.000	100	28	274	284	5	242	253	276	0.870	0.941
LOKIASV2_0141_ESMFold_hypothetical_protein	2x9e-assembly1.cif.gz_A-2	2x9e-assembly1.cif.gz_A-2 HUMAN MPS1 IN COMPLEX WITH NMS-P715	2.546E-04	1.000	100	39	272	284	18	228	253	251	0.824	0.834
LOKIASV2_0141_ESMFold_hypothetical_protein	4cva-assembly1.cif.gz_A	4cva-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	3.680E-04	1.000	100	29	271	284	11	233	255	264	0.856	0.875
LOKIASV2_0141_ESMFold_hypothetical_protein	7khj-assembly2.cif.gz_B	7khj-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state	4.543E-04	1.000	100	32	272	284	15	260	261	283	0.849	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	5xfj-assembly1.cif.gz_A	5xfj-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550M)	4.543E-04	1.000	100	28	249	284	14	264	266	274	0.782	0.944
LOKIASV2_0141_ESMFold_hypothetical_protein	5ia4-assembly1.cif.gz_A	5ia4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)	1.503E-04	1.000	100	31	274	284	4	266	269	291	0.859	0.978
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4r-assembly2.cif.gz_B	4d4r-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain	4.975E-05	1.000	100	28	278	284	10	269	270	288	0.884	0.963
LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly1.cif.gz_A	4xuf-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	3.879E-04	1.000	100	28	272	284	10	267	270	287	0.863	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_B	6pme-assembly1.cif.gz_B TRK-A IN COMPLEX WITH LIGAND	2.415E-04	1.000	100	31	274	284	7	264	271	291	0.859	0.952
LOKIASV2_0141_ESMFold_hypothetical_protein	5jfx-assembly1.cif.gz_A	5jfx-assembly1.cif.gz_A Crystal structure of TrkA in complex with PF-06273340	3.492E-04	1.000	100	28	274	284	21	268	277	281	0.870	0.895
LOKIASV2_0141_ESMFold_hypothetical_protein	6kzd-assembly1.cif.gz_A	6kzd-assembly1.cif.gz_A Crystal structure of TRKc in complex with 3-((6-(4-aminophenyl)imidazo[1,2-a]pyrazin-3-yl)ethynyl)- N-(3-isopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-2- methylbenzamide	3.680E-04	1.000	100	28	274	284	10	272	282	293	0.870	0.933
LOKIASV2_0141_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B	4nk9-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1	3.680E-04	1.000	100	28	271	284	18	254	282	275	0.859	0.840
LOKIASV2_0141_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A	4obp-assembly3.cif.gz_A MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE	1.585E-04	1.000	100	36	273	284	13	283	285	304	0.838	0.951
LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A	6itt-assembly1.cif.gz_A Crystal structure of unactivated c-KIT in complex with compound	3.142E-04	1.000	100	26	273	284	24	299	301	301	0.873	0.917
LOKIASV2_0141_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A	4umr-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	8.109E-04	1.000	100	28	271	284	5	224	313	268	0.859	0.703
LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly1.cif.gz_A	3vwa-assembly1.cif.gz_A Crystal structure of Cex1p	2.291E-04	1.000	100	21	283	284	5	277	531	299	0.926	0.514
LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	7.298E-04	0.999	99	29	243	284	6	254	255	264	0.757	0.976
LOKIASV2_0141_ESMFold_hypothetical_protein	3u51-assembly1.cif.gz_A	3u51-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC1	2.546E-04	0.999	99	30	283	284	1	251	256	291	0.894	0.980
LOKIASV2_0141_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	1.525E-03	0.999	99	66	229	284	67	221	258	179	0.577	0.601
LOKIASV2_0141_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	2.546E-04	0.999	99	36	274	284	10	235	258	262	0.842	0.876
LOKIASV2_0141_ESMFold_hypothetical_protein	5n7v-assembly1.cif.gz_A	5n7v-assembly1.cif.gz_A TTK kinase domain in complex with MPI-0479605	2.981E-04	0.999	99	36	271	284	10	239	261	263	0.831	0.881
LOKIASV2_0141_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	2.981E-04	0.999	99	25	234	284	4	242	266	263	0.739	0.898
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly1.cif.gz_A	6fnh-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	1.670E-04	0.999	99	31	273	284	7	265	277	286	0.856	0.935
LOKIASV2_0141_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A	6yky-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	1.761E-04	0.999	99	35	271	284	5	259	281	283	0.835	0.907
LOKIASV2_0141_ESMFold_hypothetical_protein	4neu-assembly1.cif.gz_A	4neu-assembly1.cif.gz_A X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline inhibitor	5.912E-04	0.999	99	30	273	284	6	283	286	305	0.859	0.972
LOKIASV2_0141_ESMFold_hypothetical_protein	4zk5-assembly1.cif.gz_A	4zk5-assembly1.cif.gz_A MAP4K4 in complex with inhibitor GNE-495	3.142E-04	0.999	99	36	273	284	9	283	286	313	0.838	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	5say-assembly2.cif.gz_B	5say-assembly2.cif.gz_B DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 2.190A, P1211, Rfree=27.7%	1.608E-03	0.999	99	28	223	284	8	213	288	224	0.690	0.715
LOKIASV2_0141_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A	4tye-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	2.683E-04	0.999	99	28	278	284	16	289	292	308	0.884	0.938
LOKIASV2_0141_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B	6xv9-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor	1.096E-04	0.999	99	28	273	284	17	287	292	299	0.866	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A	7zy6-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	3.312E-04	0.999	99	28	278	284	22	292	293	298	0.884	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	6hp9-assembly1.cif.gz_A	6hp9-assembly1.cif.gz_A Structure of the kinase domain of human DDR1 in complex with a 2-Amino-2,3-Dihydro-1H-Indene-5-Carboxamide-based inhibitor	3.312E-04	0.999	99	38	227	284	11	235	297	236	0.669	0.758
LOKIASV2_0141_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A	3wze-assembly1.cif.gz_A KDR in complex with ligand sorafenib	3.492E-04	0.999	99	26	277	284	17	297	298	308	0.887	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	8h7x-assembly1.cif.gz_B	8h7x-assembly1.cif.gz_B Crystal structure of EGFR T790M/C797S mutant in complex with brigatinib	2.546E-04	0.999	99	28	273	284	15	271	304	282	0.866	0.845
LOKIASV2_0141_ESMFold_hypothetical_protein	4yzc-assembly2.cif.gz_B	4yzc-assembly2.cif.gz_B Crystal structure of pIRE1alpha in complex with staurosporine	3.543E-03	0.999	99	28	180	284	7	143	384	163	0.539	0.357
LOKIASV2_0141_ESMFold_hypothetical_protein	5ubr-assembly1.cif.gz_A	5ubr-assembly1.cif.gz_A CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4] TRIAZIN-4-AMINE DERIVIATINE	4.248E-05	0.999	99	30	274	284	614	883	887	298	0.863	0.304
LOKIASV2_0141_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	6.232E-04	0.999	98	28	274	284	7	243	257	278	0.870	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_F	7xbr-assembly2.cif.gz_F Crystal structure of phosphorylated AtMKK5	1.856E-04	0.999	98	34	220	284	5	191	257	208	0.658	0.728
LOKIASV2_0141_ESMFold_hypothetical_protein	2zmc-assembly1.cif.gz_A	2zmc-assembly1.cif.gz_A Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form	4.789E-04	0.999	98	35	271	284	1	238	260	272	0.835	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	8.547E-04	0.999	98	33	234	284	6	218	261	234	0.711	0.816
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly1.cif.gz_A	6mzq-assembly1.cif.gz_A TAS-120 in reversible binding mode with FGFR1	3.312E-04	0.999	98	28	271	284	14	250	277	283	0.859	0.856
LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	2.981E-04	0.999	98	29	273	284	7	289	294	304	0.863	0.963
LOKIASV2_0141_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A	2xir-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-morpholinoethoxy)quinolin-4-yloxy) benzofuran-3-carboxamide)	5.048E-04	0.999	98	28	277	284	18	294	296	304	0.880	0.936
LOKIASV2_0141_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	4.089E-04	0.999	98	28	271	284	8	222	311	268	0.859	0.691
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	1.112E-03	0.999	98	28	220	284	6	197	318	216	0.680	0.604
LOKIASV2_0141_ESMFold_hypothetical_protein	2jav-assembly1.cif.gz_A	2jav-assembly1.cif.gz_A Human Kinase with pyrrole-indolinone ligand	1.172E-03	0.999	97	28	223	284	5	183	253	211	0.690	0.708
LOKIASV2_0141_ESMFold_hypothetical_protein	3cr0-assembly1.cif.gz_A	3cr0-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD259_809	2.205E-03	0.999	97	47	219	284	18	193	257	195	0.609	0.685
LOKIASV2_0141_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	1.856E-04	0.999	97	35	271	284	1	235	257	274	0.835	0.914
LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B	6c19-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN36985	5.048E-04	0.999	97	28	269	284	7	236	264	265	0.852	0.871
LOKIASV2_0141_ESMFold_hypothetical_protein	3g6g-assembly1.cif.gz_A	3g6g-assembly1.cif.gz_A Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	4.310E-04	0.999	97	28	283	284	11	259	264	282	0.901	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	7khk-assembly2.cif.gz_B	7khk-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	1.172E-03	0.999	97	32	278	284	19	265	266	284	0.870	0.929
LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	5.912E-04	0.999	97	29	274	284	2	236	284	280	0.866	0.827
LOKIASV2_0141_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A	5grn-assembly1.cif.gz_A Crystal structure of PDGFRA in Complex with WQ-C-159	9.009E-04	0.999	97	28	274	284	9	280	285	302	0.870	0.954
LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B	6xvb-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	4.543E-04	0.999	97	28	273	284	12	287	288	302	0.866	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	2.325E-03	0.999	97	28	222	284	11	190	313	205	0.687	0.575
LOKIASV2_0141_ESMFold_hypothetical_protein	3vrz-assembly2.cif.gz_B	3vrz-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	2.828E-04	0.999	97	32	274	284	175	398	431	269	0.856	0.520
LOKIASV2_0141_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	5.609E-04	0.999	96	39	272	284	18	229	254	245	0.824	0.835
LOKIASV2_0141_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	5.321E-04	0.999	96	36	271	284	10	238	260	263	0.831	0.881
LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly1.cif.gz_A	6c18-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN37115	7.298E-04	0.999	96	29	239	284	7	268	276	273	0.743	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	8pym-assembly1.cif.gz_AAA	8pym-assembly1.cif.gz_AAA Human IGF1R with inhibitor 54	2.683E-04	0.999	96	34	273	284	14	276	278	290	0.845	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	6dki-assembly1.cif.gz_A	6dki-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 19.	3.312E-04	0.999	96	31	274	284	6	267	279	287	0.859	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	1.426E-04	0.999	96	28	277	284	15	287	288	312	0.880	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_B	3eta-assembly3.cif.gz_B Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor	4.789E-04	0.999	96	30	234	284	1	229	292	247	0.722	0.784
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly1.cif.gz_A	4uwb-assembly1.cif.gz_A Fibroblast growth factor receptor 1 kinase in complex with JK-P5	4.789E-04	0.999	96	28	274	284	14	291	299	314	0.870	0.930
LOKIASV2_0141_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A	7b3m-assembly1.cif.gz_A MEK1 in complex with compound 6	5.912E-04	0.999	96	1	213	284	3	212	302	235	0.750	0.695
LOKIASV2_0141_ESMFold_hypothetical_protein	5mai-assembly1.cif.gz_A	5mai-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	2.723E-03	0.999	96	16	213	284	2	176	312	213	0.697	0.561
LOKIASV2_0141_ESMFold_hypothetical_protein	5dxh-assembly2.cif.gz_D	5dxh-assembly2.cif.gz_D p110alpha/p85alpha with compound 5	3.627E-05	0.999	96	30	282	284	711	968	981	292	0.891	0.263
LOKIASV2_0141_ESMFold_hypothetical_protein	4xv3-assembly1.cif.gz_B	4xv3-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX7922	6.568E-04	0.998	95	36	274	284	10	237	238	268	0.842	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	4.089E-04	0.998	95	38	271	284	17	239	261	259	0.824	0.854
LOKIASV2_0141_ESMFold_hypothetical_protein	4ehe-assembly1.cif.gz_A	4ehe-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor	5.912E-04	0.998	95	28	277	284	9	263	266	287	0.880	0.959
LOKIASV2_0141_ESMFold_hypothetical_protein	5o91-assembly1.cif.gz_A	5o91-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5	3.142E-04	0.998	95	35	271	284	1	242	266	273	0.835	0.910
LOKIASV2_0141_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	3.312E-04	0.998	95	28	277	284	13	282	283	314	0.880	0.954
LOKIASV2_0141_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A	4hw7-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME	6.232E-04	0.998	95	26	273	284	14	287	289	300	0.873	0.948
LOKIASV2_0141_ESMFold_hypothetical_protein	4mxc-assembly1.cif.gz_A	4mxc-assembly1.cif.gz_A Crystal structure of CMET in complex with novel inhibitor	8.109E-04	0.998	95	28	277	284	24	287	290	293	0.880	0.910
LOKIASV2_0141_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A	4r7i-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC	2.062E-04	0.998	95	28	273	284	15	288	290	300	0.866	0.945
LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly1.cif.gz_A	3ky2-assembly1.cif.gz_A Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	6.924E-04	0.998	95	28	271	284	15	280	307	302	0.859	0.866
LOKIASV2_0141_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	3.492E-04	0.998	95	28	281	284	4	297	309	327	0.894	0.951
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	5.912E-04	0.998	94	35	274	284	1	232	254	268	0.845	0.913
LOKIASV2_0141_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	6.568E-04	0.998	94	32	244	284	3	235	259	259	0.750	0.900
LOKIASV2_0141_ESMFold_hypothetical_protein	1jpa-assembly2.cif.gz_B	1jpa-assembly2.cif.gz_B Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	8.547E-04	0.998	94	13	282	284	14	267	269	314	0.951	0.944
LOKIASV2_0141_ESMFold_hypothetical_protein	5o26-assembly1.cif.gz_A	5o26-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+	3.361E-03	0.998	94	28	178	284	11	158	273	164	0.532	0.542
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyl-assembly1.cif.gz_AAA	8pyl-assembly1.cif.gz_AAA Human IGF1R with inhibitor 53	1.303E-03	0.998	94	34	220	284	12	212	277	220	0.658	0.726
LOKIASV2_0141_ESMFold_hypothetical_protein	7y4t-assembly1.cif.gz_A	7y4t-assembly1.cif.gz_A Crystal structure of cMET kinase domain bound by compound 9I	3.361E-03	0.998	94	28	219	284	13	215	281	221	0.676	0.722
LOKIASV2_0141_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A	6ylc-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	2.981E-04	0.998	94	28	271	284	5	259	282	290	0.859	0.904
LOKIASV2_0141_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E	2wtk-assembly1.cif.gz_E Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	5.399E-03	0.998	94	28	217	284	6	229	308	243	0.669	0.727
LOKIASV2_0141_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A	1t45-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	4.543E-04	0.998	94	28	280	284	42	329	331	316	0.891	0.870
LOKIASV2_0141_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	5.609E-04	0.998	94	29	278	284	2	289	459	309	0.880	0.627
LOKIASV2_0141_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A	5fi4-assembly1.cif.gz_A Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model	7.992E-05	0.998	94	30	282	284	718	989	1009	303	0.891	0.270
LOKIASV2_0141_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	1.236E-03	0.998	93	28	274	284	8	250	253	275	0.870	0.960
LOKIASV2_0141_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	9.009E-04	0.998	93	28	274	284	6	243	254	279	0.870	0.937
LOKIASV2_0141_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D	5d7v-assembly4.cif.gz_D Crystal structure of PTK6 kinase domain	5.609E-04	0.998	93	28	274	284	6	260	264	288	0.870	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	7ah3-assembly1.cif.gz_A	7ah3-assembly1.cif.gz_A Kinase domain of cSrc in complex with a pyrazolopyrimidine	6.924E-04	0.998	93	28	283	284	10	260	265	291	0.901	0.947
LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly2.cif.gz_B	2hyy-assembly2.cif.gz_B Human Abl kinase domain in complex with imatinib (STI571, Glivec)	4.543E-04	0.998	93	28	275	284	9	264	265	300	0.873	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkb-assembly1.cif.gz_A	6dkb-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10b.	5.321E-04	0.998	93	28	284	284	9	268	272	290	0.905	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	3tv6-assembly2.cif.gz_B	3tv6-assembly2.cif.gz_B Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	6.232E-04	0.998	93	28	274	284	9	270	276	284	0.870	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	6.568E-04	0.998	93	27	279	284	4	273	278	294	0.891	0.971
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkw-assembly1.cif.gz_A	6dkw-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 3.	5.912E-04	0.998	93	28	274	284	21	275	284	294	0.870	0.898
LOKIASV2_0141_ESMFold_hypothetical_protein	7v3s-assembly1.cif.gz_A	7v3s-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	1.172E-03	0.998	93	28	220	284	23	218	284	219	0.680	0.690
LOKIASV2_0141_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	2.092E-03	0.998	93	30	218	284	1	220	287	229	0.665	0.767
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly1.cif.gz_A	4uwc-assembly1.cif.gz_A Fibroblast growth factor receptor 1 kinase in complex with JK-P3	1.001E-03	0.998	93	28	274	284	13	271	300	290	0.870	0.863
LOKIASV2_0141_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B	5xgn-assembly1.cif.gz_B Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976	6.924E-04	0.998	93	34	280	284	14	274	308	293	0.870	0.847
LOKIASV2_0141_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A	3bea-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor	9.009E-04	0.998	93	28	273	284	35	301	310	295	0.866	0.861
LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_C	6p8q-assembly2.cif.gz_C EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.	2.828E-04	0.998	93	31	274	284	9	270	316	292	0.859	0.829
LOKIASV2_0141_ESMFold_hypothetical_protein	4hzs-assembly2.cif.gz_B	4hzs-assembly2.cif.gz_B Crystal structure of Ack1 kinase domain with C-terminal SH3 domain	5.321E-04	0.998	93	31	274	284	7	261	319	287	0.859	0.799
LOKIASV2_0141_ESMFold_hypothetical_protein	4q5e-assembly1.cif.gz_A	4q5e-assembly1.cif.gz_A Shigella Effector Kinase OspG bound to E2-Ub UbcH7-Ub Conjugate	1.393E-02	0.997	92	37	224	284	6	166	168	195	0.662	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	4xv1-assembly1.cif.gz_A	4xv1-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX7904	1.787E-03	0.997	92	28	274	284	8	219	239	265	0.870	0.887
LOKIASV2_0141_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	1.303E-03	0.997	92	28	274	284	7	233	247	281	0.870	0.919
LOKIASV2_0141_ESMFold_hypothetical_protein	6cz3-assembly1.cif.gz_A	6cz3-assembly1.cif.gz_A Structure of the PTK6 kinase domain bound to a type I inhibitor (3-fluoro-4-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}phenyl)(morpholin-4-yl)methanone	1.985E-03	0.997	92	28	227	284	9	204	262	222	0.704	0.748
LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly3.cif.gz_C	2hyy-assembly3.cif.gz_C Human Abl kinase domain in complex with imatinib (STI571, Glivec)	3.492E-04	0.997	92	32	283	284	6	262	262	301	0.887	0.981
LOKIASV2_0141_ESMFold_hypothetical_protein	3cpb-assembly2.cif.gz_B	3cpb-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a bisamide inhibitor	9.496E-04	0.997	92	28	274	284	14	261	263	290	0.870	0.943
LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly6.cif.gz_F	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	1.525E-03	0.997	92	32	219	284	7	207	275	221	0.662	0.731
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkg-assembly1.cif.gz_A	6dkg-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 13b.	5.912E-04	0.997	92	28	274	284	10	264	276	295	0.870	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A	6mzw-assembly1.cif.gz_A TAS-120 covalent complex with FGFR1	7.298E-04	0.997	92	28	274	284	14	274	282	304	0.870	0.926
LOKIASV2_0141_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B	6gql-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)	3.879E-04	0.997	92	28	273	284	12	285	286	300	0.866	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B	6nyb-assembly1.cif.gz_B Structure of a MAPK pathway complex	5.321E-04	0.997	92	30	220	284	7	223	289	233	0.673	0.751
LOKIASV2_0141_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A	6pl3-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 2a	6.924E-04	0.997	92	28	272	284	10	278	291	294	0.863	0.924
LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B	6gqk-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	3.879E-04	0.997	92	28	273	284	17	288	293	301	0.866	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	7vkn-assembly1.cif.gz_A	7vkn-assembly1.cif.gz_A Crystal structure of TrkA (G595R) kinase with repotrectinib	5.912E-04	0.997	92	31	274	284	9	287	297	309	0.859	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	3zos-assembly2.cif.gz_B	3zos-assembly2.cif.gz_B Structure of the DDR1 kinase domain in complex with ponatinib	8.109E-04	0.997	92	34	278	284	10	302	303	307	0.863	0.967
LOKIASV2_0141_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A	6mob-assembly1.cif.gz_A Crystal structure of KIT1 in complex with DP2976 via co-crystallization	1.055E-03	0.997	92	28	272	284	22	305	306	311	0.863	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	2.325E-03	0.997	92	27	220	284	4	188	309	215	0.683	0.599
LOKIASV2_0141_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A	8cgc-assembly1.cif.gz_A Structure of CSF1R in complex with a pyrollopyrimidine (compound 23)	8.547E-04	0.997	92	28	273	284	35	308	311	294	0.866	0.881
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly2.cif.gz_B	2pzi-assembly2.cif.gz_B Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	6.568E-04	0.997	92	28	274	284	75	319	644	283	0.870	0.380
LOKIASV2_0141_ESMFold_hypothetical_protein	4ybj-assembly1.cif.gz_A	4ybj-assembly1.cif.gz_A Type II Dasatinib Analog Crystallized with c-Src Kinase	6.232E-04	0.997	91	32	283	284	5	250	255	285	0.887	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly3.cif.gz_C	4jvg-assembly3.cif.gz_C B-Raf Kinase in Complex with Birb796	3.361E-03	0.997	91	28	271	284	9	257	258	295	0.859	0.965
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C	6nvl-assembly3.cif.gz_C FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	4.543E-04	0.997	91	29	274	284	7	261	265	285	0.866	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A	4qrc-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinib	5.321E-04	0.997	91	28	277	284	13	296	297	318	0.880	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	5k5x-assembly1.cif.gz_A	5k5x-assembly1.cif.gz_A Crystal structure of human PDGFRA	6.924E-04	0.997	91	28	282	284	39	338	345	326	0.898	0.870
LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly1.cif.gz_B	4jvg-assembly1.cif.gz_B B-Raf Kinase in Complex with Birb796	1.055E-03	0.996	90	48	274	284	22	233	259	253	0.799	0.819
LOKIASV2_0141_ESMFold_hypothetical_protein	1uwh-assembly1.cif.gz_B	1uwh-assembly1.cif.gz_B The complex of wild type B-RAF and BAY439006.	1.172E-03	0.996	90	28	277	284	9	261	264	279	0.880	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	6.568E-04	0.996	90	31	274	284	6	264	268	293	0.859	0.966
LOKIASV2_0141_ESMFold_hypothetical_protein	3cp9-assembly2.cif.gz_B	3cp9-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor	1.112E-03	0.996	90	28	274	284	15	267	269	293	0.870	0.941
LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	1.055E-03	0.996	90	26	272	284	8	272	274	298	0.870	0.967
LOKIASV2_0141_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	5.609E-04	0.996	90	29	272	284	13	274	277	301	0.859	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	3a4p-assembly1.cif.gz_A	3a4p-assembly1.cif.gz_A human c-MET kinase domain complexed with 6-benzyloxyquinoline inhibitor	1.172E-03	0.996	90	28	275	284	13	266	285	282	0.873	0.891
LOKIASV2_0141_ESMFold_hypothetical_protein	3q6u-assembly1.cif.gz_A	3q6u-assembly1.cif.gz_A Structure of the apo MET receptor kinase in the dually-phosphorylated, activated state	2.450E-03	0.996	90	5	241	284	9	275	287	283	0.835	0.930
LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	4.543E-04	0.996	90	28	273	284	23	295	297	299	0.866	0.919
LOKIASV2_0141_ESMFold_hypothetical_protein	7vko-assembly1.cif.gz_A	7vko-assembly1.cif.gz_A Crystal structure of TrkA kinase with repotrectinib	1.373E-03	0.996	90	26	274	284	11	288	297	307	0.877	0.936
LOKIASV2_0141_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A	5eak-assembly1.cif.gz_A Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	4.149E-03	0.996	90	28	213	284	6	179	305	202	0.655	0.570
LOKIASV2_0141_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A	4l45-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389E	2.723E-03	0.996	90	30	213	284	5	188	317	201	0.648	0.580
LOKIASV2_0141_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A	4l46-assembly1.cif.gz_A Crystal structures of human p70S6K1-WT	4.610E-03	0.996	90	32	213	284	8	196	318	207	0.641	0.594
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly1.cif.gz_A	2pzi-assembly1.cif.gz_A Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	5.048E-04	0.996	90	28	274	284	76	321	654	285	0.870	0.376
LOKIASV2_0141_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A	5fd2-assembly1.cif.gz_A B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	1.172E-03	0.996	89	28	220	284	9	217	264	239	0.680	0.792
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyn-assembly1.cif.gz_AAA	8pyn-assembly1.cif.gz_AAA Human IGF1R with inhibitor 56	1.055E-03	0.996	89	34	281	284	12	274	275	293	0.873	0.956
LOKIASV2_0141_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A	6wxj-assembly1.cif.gz_A CSF1R signaling is a regulator of pathogenesis in progressive MS	4.310E-04	0.996	89	28	273	284	23	277	282	284	0.866	0.904
LOKIASV2_0141_ESMFold_hypothetical_protein	6d1z-assembly1.cif.gz_A	6d1z-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one Inhibitor	9.496E-04	0.996	89	28	274	284	19	278	290	282	0.870	0.897
LOKIASV2_0141_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B	3g0f-assembly1.cif.gz_B KIT kinase domain mutant D816H in complex with sunitinib	8.672E-03	0.996	89	28	222	284	25	224	293	221	0.687	0.683
LOKIASV2_0141_ESMFold_hypothetical_protein	5dg5-assembly1.cif.gz_A	5dg5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP-4157	1.608E-03	0.996	89	2	220	284	4	231	297	257	0.771	0.768
LOKIASV2_0141_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A	3krj-assembly1.cif.gz_A cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide	1.236E-03	0.996	89	7	273	284	19	302	304	318	0.940	0.934
LOKIASV2_0141_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	1.236E-03	0.996	89	26	273	284	31	300	304	299	0.873	0.888
LOKIASV2_0141_ESMFold_hypothetical_protein	7bmk-assembly1.cif.gz_B	7bmk-assembly1.cif.gz_B ATP-Competitive Partial Antagonists-'PAIR's-Rheostatically Modulate IRE1alpha's Kinase Helix-alphaC to Segregate its RNase-Mediated Biological Outputs	8.227E-03	0.996	89	37	180	284	1	147	392	160	0.507	0.375
LOKIASV2_0141_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A	3ii5-assembly3.cif.gz_A The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	1.525E-03	0.995	88	28	274	284	9	259	262	279	0.870	0.958
LOKIASV2_0141_ESMFold_hypothetical_protein	3d94-assembly1.cif.gz_A-2	3d94-assembly1.cif.gz_A-2 Crystal structure of the insulin-like growth factor-1 receptor kinase in complex with PQIP	1.303E-03	0.995	88	34	269	284	12	249	288	267	0.831	0.826
LOKIASV2_0141_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A	3lco-assembly1.cif.gz_A Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R	1.236E-03	0.995	88	28	273	284	23	290	293	292	0.866	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G	2hak-assembly7.cif.gz_G Catalytic and ubiqutin-associated domains of MARK1/PAR-1	5.399E-03	0.995	88	28	220	284	5	178	297	203	0.680	0.586
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly2.cif.gz_B	4y83-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	5.048E-04	0.995	88	12	235	284	9	257	302	282	0.789	0.825
LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A	6gqk-assembly1.cif.gz_A Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	5.609E-04	0.995	88	28	277	284	22	304	305	314	0.880	0.928
LOKIASV2_0141_ESMFold_hypothetical_protein	3biz-assembly1.cif.gz_A	3biz-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD331618	2.205E-03	0.994	87	33	271	284	4	231	250	266	0.842	0.912
LOKIASV2_0141_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B	3c4c-assembly2.cif.gz_B B-Raf Kinase in Complex with PLX4720	1.695E-03	0.994	87	28	276	284	9	251	257	279	0.877	0.946
LOKIASV2_0141_ESMFold_hypothetical_protein	3cpc-assembly2.cif.gz_B	3cpc-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor	1.001E-03	0.994	87	46	274	284	24	260	262	273	0.806	0.905
LOKIASV2_0141_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A	7zw8-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	6.924E-04	0.994	87	28	278	284	29	300	301	302	0.884	0.904
LOKIASV2_0141_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	1.468E-02	0.994	87	28	171	284	5	144	302	154	0.507	0.464
LOKIASV2_0141_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	3soa-assembly1.cif.gz_A Full-length human CaMKII	3.025E-03	0.994	87	24	273	284	2	287	436	310	0.880	0.656
LOKIASV2_0141_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	5.998E-03	0.993	86	36	227	284	8	207	269	226	0.676	0.743
LOKIASV2_0141_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B	4f0i-assembly2.cif.gz_B Crystal structure of apo TrkA	1.787E-03	0.993	86	28	274	284	9	284	294	302	0.870	0.939
LOKIASV2_0141_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A	6d22-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor	1.236E-03	0.993	86	28	274	284	14	289	299	309	0.870	0.923
LOKIASV2_0141_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A	4r7h-assembly1.cif.gz_A Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397	7.298E-04	0.993	86	28	273	284	33	305	308	299	0.866	0.886
LOKIASV2_0141_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A	6a32-assembly1.cif.gz_A Crystal structure of PDGFRA kinase domain mutant T674I	1.608E-03	0.993	86	28	283	284	39	326	336	315	0.901	0.857
LOKIASV2_0141_ESMFold_hypothetical_protein	6w3a-assembly1.cif.gz_A	6w3a-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-7658	9.141E-03	0.993	86	28	220	284	7	220	363	235	0.680	0.590
LOKIASV2_0141_ESMFold_hypothetical_protein	7pg5-assembly1.cif.gz_A	7pg5-assembly1.cif.gz_A Crystal Structure of PI3Kalpha	3.492E-04	0.993	86	30	274	284	732	1009	1028	313	0.863	0.270
LOKIASV2_0141_ESMFold_hypothetical_protein	3dtw-assembly2.cif.gz_B	3dtw-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a benzisoxazole inhibitor	1.695E-03	0.992	85	28	274	284	14	266	269	293	0.870	0.941
LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	8.547E-04	0.992	85	34	273	284	5	287	291	306	0.845	0.973
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	2.205E-03	0.992	85	28	284	284	10	300	300	318	0.905	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	3lcs-assembly1.cif.gz_A	3lcs-assembly1.cif.gz_A Crystal Structure of the Anaplastic Lymphoma Kinase Catalytic Domain	2.092E-03	0.992	85	28	273	284	20	290	304	300	0.866	0.891
LOKIASV2_0141_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A	5x02-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101	2.450E-03	0.992	85	28	271	284	37	284	305	283	0.859	0.813
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B	4bwx-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase mutant	6.568E-04	0.992	85	31	281	284	31	286	397	294	0.884	0.645
LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly2.cif.gz_B	3vwa-assembly2.cif.gz_B Crystal structure of Cex1p	1.787E-03	0.992	85	21	283	284	5	276	529	298	0.926	0.514
LOKIASV2_0141_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	3.361E-03	0.991	84	30	271	284	10	250	301	272	0.852	0.801
LOKIASV2_0141_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A	2i0v-assembly1.cif.gz_A c-FMS tyrosine kinase in complex with a quinolone inhibitor	1.525E-03	0.991	84	34	273	284	37	299	303	286	0.845	0.868
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly3.cif.gz_C	4y85-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	2.205E-03	0.991	84	28	271	284	44	282	303	282	0.859	0.789
LOKIASV2_0141_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A	6joj-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by soaking	3.734E-03	0.991	84	28	238	284	39	328	338	303	0.743	0.858
LOKIASV2_0141_ESMFold_hypothetical_protein	7mgk-assembly3.cif.gz_C	7mgk-assembly3.cif.gz_C TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	2.870E-03	0.990	83	28	273	284	18	255	260	283	0.866	0.915
LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly1.cif.gz_A	6vg3-assembly1.cif.gz_A Structure of unliganded, inactive PTK7 kinase domain	2.450E-03	0.990	83	32	273	284	5	276	277	299	0.852	0.982
LOKIASV2_0141_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	3.361E-03	0.990	83	7	274	284	7	282	284	319	0.944	0.972
LOKIASV2_0141_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A	6ig8-assembly1.cif.gz_A Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952	1.695E-03	0.990	83	28	273	284	25	297	301	300	0.866	0.907
LOKIASV2_0141_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	6.924E-04	0.990	83	36	271	284	4	254	302	280	0.831	0.831
LOKIASV2_0141_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B	2qnj-assembly1.cif.gz_B Kinase and Ubiquitin-associated domains of MARK3/Par-1	6.665E-03	0.990	83	28	213	284	13	194	322	208	0.655	0.565
LOKIASV2_0141_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	1.985E-03	0.988	82	26	275	284	10	262	268	288	0.880	0.944
LOKIASV2_0141_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A	3krl-assembly1.cif.gz_A cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide	2.092E-03	0.988	82	28	272	284	21	280	281	288	0.863	0.925
LOKIASV2_0141_ESMFold_hypothetical_protein	3ctj-assembly1.cif.gz_A	3ctj-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor	7.805E-03	0.988	82	7	219	284	1	208	289	237	0.750	0.720
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly1.cif.gz_A	4y83-assembly1.cif.gz_A Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	1.608E-03	0.988	82	17	228	284	10	256	299	271	0.746	0.826
LOKIASV2_0141_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A	4l43-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form I)	1.016E-02	0.988	82	28	213	284	10	188	316	201	0.655	0.566
LOKIASV2_0141_ESMFold_hypothetical_protein	7d5o-assembly2.cif.gz_A	7d5o-assembly2.cif.gz_A C-Src in complex with TAS-120	3.361E-03	0.986	81	32	283	284	7	249	254	279	0.887	0.957
LOKIASV2_0141_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	3.936E-03	0.986	81	32	274	284	14	280	281	293	0.856	0.950
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly2.cif.gz_B	4y85-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	1.236E-03	0.986	81	12	271	284	9	285	306	322	0.915	0.905
LOKIASV2_0141_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	6.665E-03	0.986	81	13	228	284	56	297	395	266	0.761	0.613
LOKIASV2_0141_ESMFold_hypothetical_protein	7mgj-assembly1.cif.gz_A	7mgj-assembly1.cif.gz_A TNNI3K complexed with N-methyl-4-(4-(3-(3-(trifluoromethyl) phenyl) ureido) phenoxy)picolinamide	4.610E-03	0.984	80	28	273	284	18	257	262	284	0.866	0.916
LOKIASV2_0141_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A	2ogv-assembly1.cif.gz_A Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain	3.188E-03	0.984	80	28	273	284	39	311	317	297	0.866	0.861
LOKIASV2_0141_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A	4l44-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form II)	1.631E-02	0.984	80	34	216	284	9	201	321	213	0.644	0.601
LOKIASV2_0141_ESMFold_hypothetical_protein	5itd-assembly1.cif.gz_A	5itd-assembly1.cif.gz_A Crystal structure of PI3K alpha with PI3K delta inhibitor	5.609E-04	0.984	80	30	274	284	707	982	995	307	0.863	0.277
LOKIASV2_0141_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	1.016E-02	0.981	79	30	213	284	8	189	291	201	0.648	0.625
LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_A	3eta-assembly3.cif.gz_A Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor	2.450E-03	0.981	79	30	269	284	1	253	293	283	0.845	0.863
LOKIASV2_0141_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A	6hh1-assembly1.cif.gz_A Structure of c-Kit with allosteric inhibitor 3G8	2.205E-03	0.981	79	28	273	284	24	300	303	304	0.866	0.914
LOKIASV2_0141_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	9.141E-03	0.981	79	30	213	284	1	180	313	203	0.648	0.575
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_B	4bwk-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase	3.543E-03	0.981	79	31	280	284	30	386	387	371	0.880	0.922
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A	4bwk-assembly1.cif.gz_A Structure of Neurospora crassa PAN3 pseudokinase	1.985E-03	0.981	79	31	281	284	30	283	392	290	0.884	0.648
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly3.cif.gz_C	4y83-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	5.691E-03	0.978	78	47	235	284	62	252	293	222	0.665	0.652
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqj-assembly1.cif.gz_A	8pqj-assembly1.cif.gz_A PDGFRA wild-type kinase domain	5.691E-03	0.978	78	28	283	284	34	319	329	317	0.901	0.869
LOKIASV2_0141_ESMFold_hypothetical_protein	4fr4-assembly5.cif.gz_E	4fr4-assembly5.cif.gz_E Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	3.734E-03	0.978	78	28	271	284	9	248	342	282	0.859	0.702
LOKIASV2_0141_ESMFold_hypothetical_protein	8dwn-assembly1.cif.gz_A	8dwn-assembly1.cif.gz_A Crystal structure of bis-phosphorylated insulin receptor kinase domain	3.543E-03	0.975	77	32	269	284	6	246	286	279	0.838	0.843
LOKIASV2_0141_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A	5sw8-assembly1.cif.gz_A Crystal structure of PI3Kalpha in complex with fragments 7 and 11	6.924E-04	0.975	77	31	274	284	746	1024	1031	310	0.859	0.271
LOKIASV2_0141_ESMFold_hypothetical_protein	5fxr-assembly1.cif.gz_A	5fxr-assembly1.cif.gz_A IGFR-1R complex with a pyrimidine inhibitor.	3.936E-03	0.971	76	34	274	284	18	265	300	285	0.849	0.827
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqk-assembly1.cif.gz_A	8pqk-assembly1.cif.gz_A APO crystal structure of PDGFRA-T674I kinase domain	5.691E-03	0.971	76	28	282	284	30	315	322	315	0.898	0.888
LOKIASV2_0141_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A	4hvs-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647	5.691E-03	0.971	76	28	273	284	41	325	326	309	0.866	0.874
LOKIASV2_0141_ESMFold_hypothetical_protein	8ilv-assembly1.cif.gz_A	8ilv-assembly1.cif.gz_A Cryo-EM structure of PI3Kalpha in complex with compound 18	1.447E-03	0.971	76	30	282	284	701	963	971	297	0.891	0.271
LOKIASV2_0141_ESMFold_hypothetical_protein	4a55-assembly1.cif.gz_A	4a55-assembly1.cif.gz_A Crystal structure of p110alpha in complex with iSH2 of p85alpha and the inhibitor PIK-108	1.172E-03	0.971	76	30	281	284	711	981	1001	303	0.887	0.271
LOKIASV2_0141_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A	2i0y-assembly1.cif.gz_A cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor	1.071E-02	0.967	75	28	271	284	24	266	289	282	0.859	0.841
LOKIASV2_0141_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A	8j5x-assembly1.cif.gz_A The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	7.405E-03	0.961	74	28	272	284	10	283	296	313	0.863	0.926
LOKIASV2_0141_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	1.883E-03	0.961	74	34	271	284	2	274	314	298	0.838	0.869
LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A	7byk-assembly1.cif.gz_A Crystal structure of the Legionella pneumophila LegK7 effector kinase	4.373E-03	0.961	74	12	274	284	145	432	448	319	0.926	0.643
LOKIASV2_0141_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_D	4mne-assembly1.cif.gz_D Crystal structure of the BRAF:MEK1 complex	1.631E-02	0.956	73	36	213	284	3	184	285	198	0.627	0.639
LOKIASV2_0141_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M	3my0-assembly13.cif.gz_M Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	5.691E-03	0.956	73	28	274	284	8	296	298	318	0.870	0.970
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly1.cif.gz_A	4y85-assembly1.cif.gz_A Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	4.610E-03	0.956	73	12	227	284	9	250	307	273	0.761	0.788
LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly1.cif.gz_A	5iu2-assembly1.cif.gz_A Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors	3.543E-03	0.956	73	28	271	284	50	292	312	291	0.859	0.779
LOKIASV2_0141_ESMFold_hypothetical_protein	3c51-assembly1.cif.gz_B	3c51-assembly1.cif.gz_B Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 3.55A	2.486E-02	0.956	73	12	216	284	119	334	461	241	0.722	0.469
LOKIASV2_0141_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	1.071E-02	0.949	72	37	213	284	6	228	269	234	0.623	0.829
LOKIASV2_0141_ESMFold_hypothetical_protein	7n93-assembly1.cif.gz_A	7n93-assembly1.cif.gz_A P70 S6K1 IN COMPLEX WITH MSC2363318A-1	3.594E-02	0.941	71	32	217	284	1	209	312	215	0.655	0.670
LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly2.cif.gz_B	5iu2-assembly2.cif.gz_B Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors	5.998E-03	0.941	71	35	271	284	53	312	313	294	0.835	0.831
LOKIASV2_0141_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	1.016E-02	0.941	71	13	218	284	49	281	387	255	0.725	0.602
LOKIASV2_0141_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	1.189E-02	0.923	69	32	236	284	4	203	252	232	0.722	0.794
LOKIASV2_0141_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A	6jok-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with sunitinib by soaking	7.805E-03	0.923	69	28	282	284	37	331	338	329	0.898	0.873
LOKIASV2_0141_ESMFold_hypothetical_protein	4i4f-assembly1.cif.gz_A	4i4f-assembly1.cif.gz_A Structure of Focal Adhesion Kinase catalytic domain in complex with an allosteric binding pyrazolobenzothiazine compound.	2.014E-02	0.900	67	28	277	284	7	251	255	285	0.880	0.961
LOKIASV2_0141_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA	6t28-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)	4.677E-02	0.855	64	25	273	284	9	268	271	300	0.877	0.959
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A	8bfs-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ326	4.210E-02	0.855	64	29	273	284	12	271	274	301	0.863	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B	7byk-assembly2.cif.gz_B Crystal structure of the Legionella pneumophila LegK7 effector kinase	1.468E-02	0.837	63	12	284	284	149	452	452	349	0.961	0.673
LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_B	6k5l-assembly1.cif.gz_B The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	1.393E-02	0.817	62	13	226	284	288	536	555	281	0.754	0.449
LOKIASV2_0141_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA	6t29-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)	7.128E-02	0.692	57	29	273	284	12	271	274	283	0.863	0.949
LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_A	6k5l-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	3.594E-02	0.692	57	13	227	284	296	547	565	285	0.757	0.446
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2	8bfm-assembly1.cif.gz_A-2 Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ331	8.799E-02	0.632	55	25	273	284	9	263	265	309	0.877	0.962
LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_A	3ff0-assembly1.cif.gz_A Crystal structure of a phenazine biosynthesis-related protein (phzb2) from pseudomonas aeruginosa at 1.90 A resolution	4.568E+00	0.090	30	29	74	284	82	129	162	50	0.162	0.296
LOKIASV2_0141_ESMFold_hypothetical_protein	2lnj-assembly1.cif.gz_A	2lnj-assembly1.cif.gz_A Solution Structure of Cyanobacterial PsbP (CyanoP) from Synechocystis sp. PCC 6803	6.604E+00	0.082	29	3	75	284	66	138	170	79	0.257	0.429
LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_B	3ff0-assembly1.cif.gz_B Crystal structure of a phenazine biosynthesis-related protein (phzb2) from pseudomonas aeruginosa at 1.90 A resolution	9.059E+00	0.076	28	29	75	284	73	121	154	53	0.165	0.318
LOKIASV2_0141_ESMFold_hypothetical_protein	2xcr-assembly2.cif.gz_S	2xcr-assembly2.cif.gz_S The 3.5A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrase complexed with GSK299423 and DNA	1.207E-01	0.069	27	43	274	284	465	704	718	287	0.817	0.334
LOKIASV2_0141_ESMFold_hypothetical_protein	6qx2-assembly2.cif.gz_J	6qx2-assembly2.cif.gz_J 3.4A structure of benzoisoxazole 3 with S.aureus DNA gyrase and DNA	9.275E-02	0.063	26	43	279	284	227	469	480	293	0.835	0.506
LOKIASV2_0141_ESMFold_hypothetical_protein	4f3l-assembly1.cif.gz_A	4f3l-assembly1.cif.gz_A Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex	5.639E+00	0.057	25	32	76	284	137	181	319	47	0.158	0.141
LOKIASV2_0141_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C	6w4o-assembly1.cif.gz_C CaMKII alpha-30 Cryo-EM reconstruction	6.962E+00	0.051	24	29	71	284	66	107	126	44	0.151	0.333
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E	5ig3-assembly1.cif.gz_E Crystal structure of the human CaMKII-alpha hub	7.338E+00	0.045	23	29	75	284	64	111	125	50	0.165	0.384
LOKIASV2_0141_ESMFold_hypothetical_protein	2f86-assembly1.cif.gz_H	2f86-assembly1.cif.gz_H The Association Domain of C. elegans CaMKII	8.594E+00	0.045	23	29	71	284	70	111	129	44	0.151	0.326
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_C-2	5ig3-assembly1.cif.gz_C-2 Crystal structure of the human CaMKII-alpha hub	8.153E+00	0.045	23	29	71	284	72	113	132	44	0.151	0.318
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfn-assembly1.cif.gz_G	8bfn-assembly1.cif.gz_G E. coli Wadjet JetABC dimer of dimers	4.502E-01	0.045	23	44	282	284	119	342	597	281	0.842	0.375
LOKIASV2_0141_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A	2rgq-assembly1.cif.gz_A Crystal structure of a protein of unknown function with a cystatin-like fold (npun_r3134) from nostoc punctiforme pcc 73102 at 1.80 A resolution	6.604E+00	0.040	22	16	77	284	55	114	133	63	0.218	0.451
LOKIASV2_0141_ESMFold_hypothetical_protein	7z9g-assembly1.cif.gz_C	7z9g-assembly1.cif.gz_C E.coli gyrase holocomplex with 217 bp DNA and Albi-2	3.647E-01	0.040	22	44	278	284	230	505	517	324	0.827	0.534
LOKIASV2_0141_ESMFold_hypothetical_protein	2rfr-assembly1.cif.gz_A	2rfr-assembly1.cif.gz_A Crystal structure of an ntf2-like protein with a cystatin-like fold (saro_3722) from novosphingobium aromaticivorans dsm at 1.16 A resolution	8.594E+00	0.034	21	26	77	284	78	129	154	57	0.183	0.338
LOKIASV2_0141_ESMFold_hypothetical_protein	5iv8-assembly2.cif.gz_D	5iv8-assembly2.cif.gz_D The LPS Transporter LptDE from Klebsiella pneumoniae, core complex	7.735E+00	0.029	20	29	88	284	56	124	149	71	0.211	0.463
LOKIASV2_0141_ESMFold_hypothetical_protein	6rku-assembly1.cif.gz_A	6rku-assembly1.cif.gz_A E. coli DNA Gyrase - DNA binding and cleavage domain in State 1	5.558E-01	0.029	20	44	278	284	230	499	511	321	0.827	0.528
LOKIASV2_0141_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A	7urz-assembly1.cif.gz_A Hexadecameric hub domain of CaMKII beta	9.059E+00	0.024	19	26	75	284	55	107	119	55	0.176	0.445
LOKIASV2_0141_ESMFold_hypothetical_protein	4kwy-assembly1.cif.gz_A	4kwy-assembly1.cif.gz_A Crystal structure of a putative lipoprotein (CC_3750) from Caulobacter crescentus CB15 at 2.40 A resolution	8.153E+00	0.024	19	29	77	284	45	101	137	57	0.173	0.416
LOKIASV2_0141_ESMFold_hypothetical_protein	6qbd-assembly2.cif.gz_B	6qbd-assembly2.cif.gz_B Crystal structure of NLPPya P41A, D44N, N48E mutant	6.962E+00	0.024	19	38	75	284	72	109	206	38	0.134	0.184
LOKIASV2_0141_ESMFold_hypothetical_protein	3cyg-assembly2.cif.gz_A	3cyg-assembly2.cif.gz_A Crystal structure of an uncharacterized protein from Fervidobacterium nodosum Rt17-B1	9.059E+00	0.024	19	12	101	284	54	148	215	100	0.317	0.442
LOKIASV2_0141_ESMFold_hypothetical_protein	6yjz-assembly1.cif.gz_B	6yjz-assembly1.cif.gz_B Crystal structure of mouse pyridoxal kinase in apo form	9.059E+00	0.024	19	41	95	284	191	264	308	76	0.194	0.240
LOKIASV2_0141_ESMFold_hypothetical_protein	1um2-assembly2.cif.gz_B	1um2-assembly2.cif.gz_B Crystal Structure of the Vma1-Derived Endonuclease with the Ligated Extein Segment	4.815E+00	0.024	19	27	116	284	70	141	419	92	0.317	0.172
LOKIASV2_0141_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2	4kz1-assembly1.cif.gz_A-2 Crystal structure of the soluble domain of VirB8 from Bartonella grahamii	8.153E+00	0.020	18	13	86	284	39	122	135	90	0.261	0.622
LOKIASV2_0141_ESMFold_hypothetical_protein	5nnw-assembly2.cif.gz_B	5nnw-assembly2.cif.gz_B NLPPya in complex with glucosamine	6.266E+00	0.020	18	38	74	284	71	105	202	37	0.130	0.173
LOKIASV2_0141_ESMFold_hypothetical_protein	7bt5-assembly1.cif.gz_A	7bt5-assembly1.cif.gz_A Crystal structure of plasmodium LysRS complexing with an antitumor compound	5.639E+00	0.016	17	10	149	284	174	354	482	183	0.493	0.376
LOKIASV2_0141_ESMFold_hypothetical_protein	7nyw-assembly1.cif.gz_A	7nyw-assembly1.cif.gz_A Cryo-EM structure of the MukBEF-MatP-DNA head module	1.046E+00	0.016	17	44	283	284	97	382	685	327	0.845	0.418
LOKIASV2_0141_ESMFold_hypothetical_protein	7o3x-assembly1.cif.gz_E	7o3x-assembly1.cif.gz_E Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	4.111E+00	0.014	16	81	281	284	4	145	215	201	0.708	0.660
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_B	8dk3-assembly1.cif.gz_B CryoEM structure of Pseudomonas aeruginosa PA14 JetC ATPase domain bound to DNA and cWHD domain of JetA	2.844E+00	0.014	16	36	273	284	102	307	450	260	0.838	0.458
LOKIASV2_0141_ESMFold_hypothetical_protein	6hcv-assembly1.cif.gz_A	6hcv-assembly1.cif.gz_A Crystal Structure of Lysyl-tRNA Synthetase from Plasmodium falciparum complexed with a chromone ligand	5.639E+00	0.014	16	11	160	284	172	359	480	193	0.528	0.392
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk1-assembly1.cif.gz_D	8dk1-assembly1.cif.gz_D CryoEM structure of JetABC (head construct) from Pseudomonas aeruginosa PA14	2.428E+00	0.014	16	26	282	284	70	291	509	288	0.905	0.436
LOKIASV2_0141_ESMFold_hypothetical_protein	8oip-assembly1.cif.gz_Ae	8oip-assembly1.cif.gz_Ae 28S mammalian mitochondrial small ribosomal subunit with mtRF1 and P-site tRNA	5.350E+00	0.014	16	72	283	284	302	485	588	226	0.746	0.313
LOKIASV2_0141_ESMFold_hypothetical_protein	1jva-assembly2.cif.gz_B	1jva-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE BEARING THE N AND C EXTEIN PROPEPTIDES	2.844E+00	0.011	15	27	226	284	77	305	430	266	0.704	0.533
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk2-assembly1.cif.gz_C	8dk2-assembly1.cif.gz_C CryoEM structure of Pseudomonas aeruginosa PA14 JetABC in an unclamped state trapped in ATP dependent dimeric form	1.770E+00	0.011	15	36	283	284	102	382	723	333	0.873	0.389
LOKIASV2_0141_ESMFold_hypothetical_protein	4ycv-assembly2.cif.gz_C	4ycv-assembly2.cif.gz_C Crystal structure of cladosporin in complex with plasmodium lysyl-tRNA synthetase	9.059E+00	0.010	14	12	149	284	176	356	485	191	0.486	0.373
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_A	8dk3-assembly1.cif.gz_A CryoEM structure of Pseudomonas aeruginosa PA14 JetC ATPase domain bound to DNA and cWHD domain of JetA	5.944E+00	0.009	13	36	218	284	102	249	455	191	0.644	0.325
LOKIASV2_0141_ESMFold_hypothetical_protein	6l4q-assembly1.cif.gz_B	6l4q-assembly1.cif.gz_B Crystal Structure of Lysyl-tRNA Synthetase from Plasmodium falciparum complexed with L-lysine and Clado-B	7.735E+00	0.009	13	29	149	284	243	356	485	133	0.426	0.235
LOKIASV2_0141_ESMFold_hypothetical_protein	6bni-assembly1.cif.gz_A	6bni-assembly1.cif.gz_A Crystal Structure of Lysyl-tRNA Synthetase from Cryptosporidium parvum complexed with L-lysine and Adenosine	6.962E+00	0.009	13	48	215	284	247	466	502	227	0.592	0.438
LOKIASV2_0141_ESMFold_hypothetical_protein	7dkv-assembly1.cif.gz_A	7dkv-assembly1.cif.gz_A Crystal structure of TxGH116 E441A nucleophile mutant from Thermoanaerobacterium xylanolyticum with cellotriose	9.059E+00	0.009	13	29	277	284	204	612	769	432	0.877	0.532
LOKIASV2_0141_ESMFold_hypothetical_protein	7zog-assembly2.cif.gz_C	7zog-assembly2.cif.gz_C Crystal structure of Cryptosporidium parvum -Plasmodium falciparum mutant lysyl tRNA synthetase in complex with inhibitor	8.594E+00	0.008	12	10	149	284	227	352	485	152	0.493	0.260
